Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Conference/Events
European Hematology Association to hold virtual meeting » 04:55
06/13/21
06/13
04:55
06/13/21
04:55
APTO

Aptose Biosciences

$3.75 /

-1.79 (-32.31%)

, MBIO

Mustang Bio

$3.79 /

-0.03 (-0.79%)

, QURE

uniQure

$36.05 /

-0.63 (-1.72%)

, RIGL

Rigel Pharmaceuticals

$4.02 /

-0.16 (-3.83%)

, MGTA

Magenta Therapeutics

$11.57 /

-0.15 (-1.28%)

, MEIP

MEI Pharma

$3.28 /

+0.08 (+2.50%)

, CRIS

Curis

$8.00 /

-4.72 (-37.11%)

, XLRN

Acceleron

$133.36 /

+2.36 (+1.80%)

, EPZM

Epizyme

$8.53 /

+0.08 (+0.95%)

, INCY

Incyte

$82.59 /

-4.97 (-5.68%)

, ORTX

Orchard Therapeutics

$5.12 /

-0.05 (-0.97%)

, TGTX

TG Therapeutics

$37.81 /

-0.14 (-0.37%)

, EQ

Equillium

$6.12 /

-0.85 (-12.20%)

, JAZZ

Jazz Pharmaceuticals

$186.19 /

-0.21 (-0.11%)

, VRTX

Vertex Pharmaceuticals

$193.02 /

-23.93 (-11.03%)

, SGEN

Seagen

$156.27 /

-2.3 (-1.45%)

, IMRA

Imara

$8.56 /

-0.235 (-2.67%)

, GBT

Global Blood Therapeutics

$40.64 /

-1.01 (-2.42%)

, BGNE

BeiGene

$346.81 /

-6.09 (-1.73%)

, APLS

Apellis

$62.10 /

+1.33 (+2.19%)

, AGIO

Agios Pharmaceuticals

$57.80 /

-1.69 (-2.84%)

, FMTX

Forma Therapeutics

$22.81 /

-5.2 (-18.56%)

, KROS

Keros Therapeutics

$51.75 /

-0.61 (-1.17%)

, CYAD

Celyad

$5.75 /

-0.22 (-3.69%)

, ALXN

Alexion

$181.64 /

-0.41 (-0.23%)

EHA 2021 Virtual Congress…

EHA 2021 Virtual Congress to be held on June 9-17. Webcast Link

ShowHide Related Items >><<
XLRN Acceleron
$133.36 /

+2.36 (+1.80%)

VRTX Vertex Pharmaceuticals
$193.02 /

-23.93 (-11.03%)

TGTX TG Therapeutics
$37.81 /

-0.14 (-0.37%)

SGEN Seagen
$156.27 /

-2.3 (-1.45%)

RIGL Rigel Pharmaceuticals
$4.02 /

-0.16 (-3.83%)

QURE uniQure
$36.05 /

-0.63 (-1.72%)

ORTX Orchard Therapeutics
$5.12 /

-0.05 (-0.97%)

MGTA Magenta Therapeutics
$11.57 /

-0.15 (-1.28%)

MEIP MEI Pharma
$3.28 /

+0.08 (+2.50%)

MBIO Mustang Bio
$3.79 /

-0.03 (-0.79%)

KROS Keros Therapeutics
$51.75 /

-0.61 (-1.17%)

JAZZ Jazz Pharmaceuticals
$186.19 /

-0.21 (-0.11%)

INCY Incyte
$82.59 /

-4.97 (-5.68%)

IMRA Imara
$8.56 /

-0.235 (-2.67%)

GBT Global Blood Therapeutics
$40.64 /

-1.01 (-2.42%)

FMTX Forma Therapeutics
$22.81 /

-5.2 (-18.56%)

EQ Equillium
$6.12 /

-0.85 (-12.20%)

EPZM Epizyme
$8.53 /

+0.08 (+0.95%)

CYAD Celyad
$5.75 /

-0.22 (-3.69%)

CRIS Curis
$8.00 /

-4.72 (-37.11%)

BGNE BeiGene
$346.81 /

-6.09 (-1.73%)

APTO Aptose Biosciences
$3.75 /

-1.79 (-32.31%)

APLS Apellis
$62.10 /

+1.33 (+2.19%)

ALXN Alexion
$181.64 /

-0.41 (-0.23%)

AGIO Agios Pharmaceuticals
$57.80 /

-1.69 (-2.84%)

APTO Aptose Biosciences
$3.75 /

-1.79 (-32.31%)

02/22/21 JonesTrading
Aptose Biosciences resumed with a Buy at JonesTrading
10/19/20 Cantor Fitzgerald
Aptose Biosciences initiated with an Overweight at Cantor Fitzgerald
09/22/20 Alliance Global Partners
Aptose Biosciences initiated with a Buy at Alliance Global Partners
09/18/20 Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology
MBIO Mustang Bio
$3.79 /

-0.03 (-0.79%)

05/17/21 BTIG
Mustang Bio initiated with a Buy at BTIG
05/17/21 BTIG
Mustang Bio initiated with a Buy at BTIG
05/12/21 Cantor Fitzgerald
Mustang Bio EHA abstract data 'looks promising,' says Cantor Fitzgerald
12/23/20 B. Riley
Mustang Bio transferred with a Buy at B. Riley Securities
QURE uniQure
$36.05 /

-0.63 (-1.72%)

05/20/21 UBS
uniQure initiated with a Neutral at UBS
05/19/21 H.C. Wainwright
uniQure price target raised to $90 from $80 at H.C. Wainwright
04/26/21 Chardan
Chardan sees 'stock momentum' for uniQure after clinical hold lift
04/26/21 Credit Suisse
uniQure assumed with an Outperform at Credit Suisse
RIGL Rigel Pharmaceuticals
$4.02 /

-0.16 (-3.83%)

06/11/21 BMO Capital
Rigel Pharmaceuticals coverage transferred at BMO Capital
05/12/21 Cantor Fitzgerald
Rigel rallying on Curis IRAK4 program data, says Cantor Fitzgerald
04/13/21 Piper Sandler
Rigel results in severe COVID-19 trial 'pretty dramatic,' says Piper Sandler
02/18/21 H.C. Wainwright
Rigel Pharmaceuticals price target raised to $11 from $8 at H.C. Wainwright
MGTA Magenta Therapeutics
$11.57 /

-0.15 (-1.28%)

05/18/21 B. Riley
Magenta Therapeutics initiated with a Buy, $21 target at B. Riley
05/17/21 B. Riley
Magenta Therapeutics initiated with a Buy at B. Riley
05/13/21 Mizuho
Magenta Therapeutics price target raised to $17 from $16 at Mizuho
01/07/21
Fly Intel: Top five analyst initiations
MEIP MEI Pharma
$3.28 /

+0.08 (+2.50%)

04/26/21 Wells Fargo
MEI Pharma likely to expand scope of voruciclib development, says Wells Fargo
10/12/20 Brookline
MEI Pharma initiated with a Buy at Brookline
09/22/20 Alliance Global Partners
MEI Pharma initiated with a Buy at Alliance Global Partners
07/06/20 Truist
MEI Pharma price target lowered to $12 from $16 at SunTrust
CRIS Curis
$8.00 /

-4.72 (-37.11%)

05/13/21 B. Riley
Curis price target raised to $22 from $19 at B. Riley
05/13/21 Cantor Fitzgerald
Curis price target raised to $24 from $15 at Cantor Fitzgerald
05/12/21 Cantor Fitzgerald
Initial look from Curis EHA updates 'very positive,' says Cantor Fitzgerald
XLRN Acceleron
$133.36 /

+2.36 (+1.80%)

06/11/21 H.C. Wainwright
Acceleron results for Phase 2 BEYOND study 'impressive,' says H.C. Wainwright
05/19/21 Piper Sandler
Piper remains bullish on Acceleron after Phase 2 PULSAR OLE, SPECTRA updates
04/26/21 Credit Suisse
Acceleron assumed with an Outperform at Credit Suisse
03/23/21
Fly Intel: Top five analyst downgrades
EPZM Epizyme
$8.53 /

+0.08 (+0.95%)

05/07/21 SVB Leerink
Epizyme upgraded to Outperform from Market Perform at SVB Leerink
04/23/21 Cowen
Epizyme transferred with Outperform at Cowen
03/30/21 Credit Suisse
Epizyme initiated with an Outperform at Credit Suisse
03/30/21 Credit Suisse
Epizyme initiated with an Outperform at Credit Suisse
INCY Incyte
$82.59 /

-4.97 (-5.68%)

02/10/21 SVB Leerink
Incyte downgraded to Market Perform from Outperform at SVB Leerink
01/07/21 Truist
Incyte initiated with a Buy at Truist
01/07/21 Truist
Incyte initiated with a Buy at Truist
01/04/21 Guggenheim
Incyte upgraded to Buy from Neutral at Guggenheim
ORTX Orchard Therapeutics
$5.12 /

-0.05 (-0.97%)

03/10/21 Stifel
Stifel says Bluebird update on AML provides 'some relief' to other LV players
03/02/21 JPMorgan
Orchard Therapeutics assumed with an Overweight at JPMorgan
03/01/21 Stifel
Orchard Therapeutics initiated with a Buy at Stifel
02/18/21 Goldman Sachs
Orchard selloff on Bluebird Bio news overdone, says Goldman Sachs
TGTX TG Therapeutics
$37.81 /

-0.14 (-0.37%)

04/20/21
Fly Intel: Top five analyst initiations
04/20/21 Goldman Sachs
TG Therapeutics initiated with a Neutral at Goldman Sachs
04/19/21 Cantor Fitzgerald
TG Therapeutics price target raised to $74 from $68 at Cantor Fitzgerald
04/19/21 H.C. Wainwright
TG Therapeutics price target raised to $89 from $79 at H.C. Wainwright
EQ Equillium
$6.12 /

-0.85 (-12.20%)

03/03/21
Fly Intel: Top five analyst initiations
03/03/21 JonesTrading
Equillium initiated with a Buy at JonesTrading
11/30/20 H.C. Wainwright
Equillium price target lowered to $12 from $22 at H.C. Wainwright
07/14/20 H.C. Wainwright
Equillium price target raised to $24 from $14 at H.C. Wainwright
JAZZ Jazz Pharmaceuticals
$186.19 /

-0.21 (-0.11%)

05/19/21
Fly Intel: Top five analyst initiations
05/19/21 JPMorgan
Jazz Pharmaceuticals resumed with an Overweight at JPMorgan
05/17/21 H.C. Wainwright
Jazz Pharmaceuticals price target raised to $212 from $207 at H.C. Wainwright
04/21/21 Cantor Fitzgerald
Jazz Pharmaceuticals price target raised to $198 from $185 at Cantor Fitzgerald
VRTX Vertex Pharmaceuticals
$193.02 /

-23.93 (-11.03%)

06/11/21 Roth Capital
Crispr Therapeutics reported 'robust' sickle cell data, says Roth Capital
06/11/21
Fly Intel: Top five analyst downgrades
06/11/21 Stifel
Vertex shares look 'cheap' at aftermarket levels, says Stifel
06/11/21 Cantor Fitzgerald
Vertex Pharmaceuticals price target lowered to $281 from $285 at Cantor Fitzgerald
SGEN Seagen
$156.27 /

-2.3 (-1.45%)

05/17/21 Evercore ISI
Seagen initiated with an In Line at Evercore ISI
04/30/21 Piper Sandler
Seagen price target lowered to $160 from $170 at Piper Sandler
04/12/21 B. Riley
B. Riley calls Agenus the next Seagen, reiterates $8 target
03/30/21 Credit Suisse
Seagen initiated with a Neutral at Credit Suisse
IMRA Imara
$8.56 /

-0.235 (-2.67%)

03/08/21 SVB Leerink
Imara price target lowered to $42 from $59 at SVB Leerink
01/06/21 SVB Leerink
Imara selloff a potential buying opportunity, says SVB Leerink
08/17/20
Fly Intel: Top five analyst upgrades
08/17/20 Citi
Imara upgraded to Buy from Neutral at Citi
GBT Global Blood Therapeutics
$40.64 /

-1.01 (-2.42%)

05/07/21 Cantor Fitzgerald
Global Blood Therapeutics price target lowered to $110 from $120 at Cantor Fitzgerald
05/06/21 Piper Sandler
Global Blood price target lowered to $45 from $50 at Piper Sandler
04/14/21
Fly Intel: Top five analyst initiations
04/14/21 SVB Leerink
SVB Leerink bullish on Global Blood Therapeutics, initiates with an Outperform
BGNE BeiGene
$346.81 /

-6.09 (-1.73%)

03/16/21 HSBC
BeiGene price target raised to $385 from $296 at HSBC
03/08/21 China Renaissance
BeiGene initiated with a Buy at China Renaissance
03/04/21 Goldman Sachs
Five Prime acquisition 'a strategic positive' for Amgen, says Goldman Sachs
03/01/21
Fly Intel: Top five analyst downgrades
APLS Apellis
$62.10 /

+1.33 (+2.19%)

05/20/21 UBS
Apellis initiated with a Buy at UBS
05/18/21 BMO Capital
Apellis price target raised to $68 from $64 at BMO Capital
05/17/21 Oppenheimer
Apellis price target raised to $67 from $64 at Oppenheimer
05/17/21 Raymond James
Apellis price target raised to $115 from $104 at Raymond James
AGIO Agios Pharmaceuticals
$57.80 /

-1.69 (-2.84%)

06/10/21 H.C. Wainwright
Agios Pharmaceuticals initiated with a Buy at H.C. Wainwright
04/30/21 Goldman Sachs
Agios Pharmaceuticals reinstated with a Neutral at Goldman Sachs
04/30/21 Barclays
Agios Pharmaceuticals price target raised to $70 from $65 at Barclays
03/30/21 Piper Sandler
Agios should rally on Forma Therapeutics data, says Piper Sandler
FMTX Forma Therapeutics
$22.81 /

-5.2 (-18.56%)

03/31/21 H.C. Wainwright
Forma Therapeutics price target raised to $55 from $53 at H.C. Wainwright
02/17/21
Fly Intel: Top five analyst initiations
02/17/21 Oppenheimer
Forma Therapeutics initiated with an Outperform at Oppenheimer
KROS Keros Therapeutics
$51.75 /

-0.61 (-1.17%)

12/08/20 SVB Leerink
Keros Therapeutics price target raised to $80 from $42 at SVB Leerink
12/08/20 H.C. Wainwright
Keros Therapeutics price target raised to $100 from $50 at H.C. Wainwright
12/08/20 Piper Sandler
Keros Therapeutics price target raised to $95 from $75 at Piper Sandler
11/18/20 Piper Sandler
Keros Therapeutics price target raised to $75 from $55 at Piper Sandler
CYAD Celyad
$5.75 /

-0.22 (-3.69%)

03/25/21 JonesTrading
Celyad downgraded to Hold from Buy at JonesTrading
12/08/20 H.C. Wainwright
Celyad price target lowered to $18 from $22 at H.C. Wainwright
ALXN Alexion
$181.64 /

-0.41 (-0.23%)

05/05/21
Fly Intel: Top five analyst upgrades
05/05/21 Oppenheimer
Alexion upgraded to Outperform from Perform at Oppenheimer
05/03/21 SVB Leerink
Alexion price target raised to $173 from $156 at SVB Leerink
04/30/21 Wedbush
Alexion's Q1 report 'uneventful' after FTC grants deal clearance, says Wedbush
XLRN Acceleron
$133.36 /

+2.36 (+1.80%)

VRTX Vertex Pharmaceuticals
$193.02 /

-23.93 (-11.03%)

TGTX TG Therapeutics
$37.81 /

-0.14 (-0.37%)

SGEN Seagen
$156.27 /

-2.3 (-1.45%)

RIGL Rigel Pharmaceuticals
$4.02 /

-0.16 (-3.83%)

QURE uniQure
$36.05 /

-0.63 (-1.72%)

ORTX Orchard Therapeutics
$5.12 /

-0.05 (-0.97%)

MGTA Magenta Therapeutics
$11.57 /

-0.15 (-1.28%)

MEIP MEI Pharma
$3.28 /

+0.08 (+2.50%)

MBIO Mustang Bio
$3.79 /

-0.03 (-0.79%)

KROS Keros Therapeutics
$51.75 /

-0.61 (-1.17%)

JAZZ Jazz Pharmaceuticals
$186.19 /

-0.21 (-0.11%)

INCY Incyte
$82.59 /

-4.97 (-5.68%)

IMRA Imara
$8.56 /

-0.235 (-2.67%)

GBT Global Blood Therapeutics
$40.64 /

-1.01 (-2.42%)

FMTX Forma Therapeutics
$22.81 /

-5.2 (-18.56%)

EQ Equillium
$6.12 /

-0.85 (-12.20%)

EPZM Epizyme
$8.53 /

+0.08 (+0.95%)

CRIS Curis
$8.00 /

-4.72 (-37.11%)

BGNE BeiGene
$346.81 /

-6.09 (-1.73%)

APTO Aptose Biosciences
$3.75 /

-1.79 (-32.31%)

APLS Apellis
$62.10 /

+1.33 (+2.19%)

ALXN Alexion
$181.64 /

-0.41 (-0.23%)

AGIO Agios Pharmaceuticals
$57.80 /

-1.69 (-2.84%)

  • 15
    Dec
  • 09
    Dec
  • 11
    Dec
  • 02
    Dec
  • 13
    Nov
  • 14
    Aug
  • 16
    Jul
  • 01
    Jul
  • 25
    Jun
  • 19
    Jun
VRTX Vertex Pharmaceuticals
$193.02 /

-23.93 (-11.03%)

RIGL Rigel Pharmaceuticals
$4.02 /

-0.16 (-3.83%)

ORTX Orchard Therapeutics
$5.12 /

-0.05 (-0.97%)

JAZZ Jazz Pharmaceuticals
$186.19 /

-0.21 (-0.11%)

INCY Incyte
$82.59 /

-4.97 (-5.68%)

EPZM Epizyme
$8.53 /

+0.08 (+0.95%)

VRTX Vertex Pharmaceuticals
$193.02 /

-23.93 (-11.03%)

TGTX TG Therapeutics
$37.81 /

-0.14 (-0.37%)

SGEN Seagen
$156.27 /

-2.3 (-1.45%)

QURE uniQure
$36.05 /

-0.63 (-1.72%)

MBIO Mustang Bio
$3.79 /

-0.03 (-0.79%)

JAZZ Jazz Pharmaceuticals
$186.19 /

-0.21 (-0.11%)

INCY Incyte
$82.59 /

-4.97 (-5.68%)

IMRA Imara
$8.56 /

-0.235 (-2.67%)

GBT Global Blood Therapeutics
$40.64 /

-1.01 (-2.42%)

EQ Equillium
$6.12 /

-0.85 (-12.20%)

CRIS Curis
$8.00 /

-4.72 (-37.11%)

APTO Aptose Biosciences
$3.75 /

-1.79 (-32.31%)

APLS Apellis
$62.10 /

+1.33 (+2.19%)

ALXN Alexion
$181.64 /

-0.41 (-0.23%)

VRTX Vertex Pharmaceuticals
$193.02 /

-23.93 (-11.03%)

INCY Incyte
$82.59 /

-4.97 (-5.68%)

FMTX Forma Therapeutics
$22.81 /

-5.2 (-18.56%)

EQ Equillium
$6.12 /

-0.85 (-12.20%)

CRIS Curis
$8.00 /

-4.72 (-37.11%)

APLS Apellis
$62.10 /

+1.33 (+2.19%)

ALXN Alexion
$181.64 /

-0.41 (-0.23%)

Yesterday
Conference/Events
European Hematology Association to hold virtual meeting » 04:55
06/12/21
06/12
04:55
06/12/21
04:55
APTO

Aptose Biosciences

$3.75 /

-1.79 (-32.31%)

, MBIO

Mustang Bio

$3.79 /

-0.03 (-0.79%)

, QURE

uniQure

$36.05 /

-0.63 (-1.72%)

, RIGL

Rigel Pharmaceuticals

$4.02 /

-0.16 (-3.83%)

, MGTA

Magenta Therapeutics

$11.57 /

-0.15 (-1.28%)

, MEIP

MEI Pharma

$3.28 /

+0.08 (+2.50%)

, CRIS

Curis

$8.00 /

-4.72 (-37.11%)

, XLRN

Acceleron

$133.36 /

+2.36 (+1.80%)

, EPZM

Epizyme

$8.53 /

+0.08 (+0.95%)

, INCY

Incyte

$82.59 /

-4.97 (-5.68%)

, ORTX

Orchard Therapeutics

$5.12 /

-0.05 (-0.97%)

, TGTX

TG Therapeutics

$37.81 /

-0.14 (-0.37%)

, EQ

Equillium

$6.12 /

-0.85 (-12.20%)

, JAZZ

Jazz Pharmaceuticals

$186.19 /

-0.21 (-0.11%)

, VRTX

Vertex Pharmaceuticals

$193.02 /

-23.93 (-11.03%)

, SGEN

Seagen

$156.27 /

-2.3 (-1.45%)

, IMRA

Imara

$8.56 /

-0.235 (-2.67%)

, GBT

Global Blood Therapeutics

$40.64 /

-1.01 (-2.42%)

, BGNE

BeiGene

$346.81 /

-6.09 (-1.73%)

, APLS

Apellis

$62.10 /

+1.33 (+2.19%)

, AGIO

Agios Pharmaceuticals

$57.80 /

-1.69 (-2.84%)

, FMTX

Forma Therapeutics

$22.81 /

-5.2 (-18.56%)

, KROS

Keros Therapeutics

$51.75 /

-0.61 (-1.17%)

, CYAD

Celyad

$5.75 /

-0.22 (-3.69%)

, ALXN

Alexion

$181.64 /

-0.41 (-0.23%)

EHA 2021 Virtual Congress…

EHA 2021 Virtual Congress to be held on June 9-17. Webcast Link

ShowHide Related Items >><<
XLRN Acceleron
$133.36 /

+2.36 (+1.80%)

VRTX Vertex Pharmaceuticals
$193.02 /

-23.93 (-11.03%)

TGTX TG Therapeutics
$37.81 /

-0.14 (-0.37%)

SGEN Seagen
$156.27 /

-2.3 (-1.45%)

RIGL Rigel Pharmaceuticals
$4.02 /

-0.16 (-3.83%)

QURE uniQure
$36.05 /

-0.63 (-1.72%)

ORTX Orchard Therapeutics
$5.12 /

-0.05 (-0.97%)

MGTA Magenta Therapeutics
$11.57 /

-0.15 (-1.28%)

MEIP MEI Pharma
$3.28 /

+0.08 (+2.50%)

MBIO Mustang Bio
$3.79 /

-0.03 (-0.79%)

KROS Keros Therapeutics
$51.75 /

-0.61 (-1.17%)

JAZZ Jazz Pharmaceuticals
$186.19 /

-0.21 (-0.11%)

INCY Incyte
$82.59 /

-4.97 (-5.68%)

IMRA Imara
$8.56 /

-0.235 (-2.67%)

GBT Global Blood Therapeutics
$40.64 /

-1.01 (-2.42%)

FMTX Forma Therapeutics
$22.81 /

-5.2 (-18.56%)

EQ Equillium
$6.12 /

-0.85 (-12.20%)

EPZM Epizyme
$8.53 /

+0.08 (+0.95%)

CYAD Celyad
$5.75 /

-0.22 (-3.69%)

CRIS Curis
$8.00 /

-4.72 (-37.11%)

BGNE BeiGene
$346.81 /

-6.09 (-1.73%)

APTO Aptose Biosciences
$3.75 /

-1.79 (-32.31%)

APLS Apellis
$62.10 /

+1.33 (+2.19%)

ALXN Alexion
$181.64 /

-0.41 (-0.23%)

AGIO Agios Pharmaceuticals
$57.80 /

-1.69 (-2.84%)

APTO Aptose Biosciences
$3.75 /

-1.79 (-32.31%)

02/22/21 JonesTrading
Aptose Biosciences resumed with a Buy at JonesTrading
10/19/20 Cantor Fitzgerald
Aptose Biosciences initiated with an Overweight at Cantor Fitzgerald
09/22/20 Alliance Global Partners
Aptose Biosciences initiated with a Buy at Alliance Global Partners
09/18/20 Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology
MBIO Mustang Bio
$3.79 /

-0.03 (-0.79%)

05/17/21 BTIG
Mustang Bio initiated with a Buy at BTIG
05/17/21 BTIG
Mustang Bio initiated with a Buy at BTIG
05/12/21 Cantor Fitzgerald
Mustang Bio EHA abstract data 'looks promising,' says Cantor Fitzgerald
12/23/20 B. Riley
Mustang Bio transferred with a Buy at B. Riley Securities
QURE uniQure
$36.05 /

-0.63 (-1.72%)

05/20/21 UBS
uniQure initiated with a Neutral at UBS
05/19/21 H.C. Wainwright
uniQure price target raised to $90 from $80 at H.C. Wainwright
04/26/21 Chardan
Chardan sees 'stock momentum' for uniQure after clinical hold lift
04/26/21 Credit Suisse
uniQure assumed with an Outperform at Credit Suisse
RIGL Rigel Pharmaceuticals
$4.02 /

-0.16 (-3.83%)

06/11/21 BMO Capital
Rigel Pharmaceuticals coverage transferred at BMO Capital
05/12/21 Cantor Fitzgerald
Rigel rallying on Curis IRAK4 program data, says Cantor Fitzgerald
04/13/21 Piper Sandler
Rigel results in severe COVID-19 trial 'pretty dramatic,' says Piper Sandler
02/18/21 H.C. Wainwright
Rigel Pharmaceuticals price target raised to $11 from $8 at H.C. Wainwright
MGTA Magenta Therapeutics
$11.57 /

-0.15 (-1.28%)

05/18/21 B. Riley
Magenta Therapeutics initiated with a Buy, $21 target at B. Riley
05/17/21 B. Riley
Magenta Therapeutics initiated with a Buy at B. Riley
05/13/21 Mizuho
Magenta Therapeutics price target raised to $17 from $16 at Mizuho
01/07/21
Fly Intel: Top five analyst initiations
MEIP MEI Pharma
$3.28 /

+0.08 (+2.50%)

04/26/21 Wells Fargo
MEI Pharma likely to expand scope of voruciclib development, says Wells Fargo
10/12/20 Brookline
MEI Pharma initiated with a Buy at Brookline
09/22/20 Alliance Global Partners
MEI Pharma initiated with a Buy at Alliance Global Partners
07/06/20 Truist
MEI Pharma price target lowered to $12 from $16 at SunTrust
CRIS Curis
$8.00 /

-4.72 (-37.11%)

05/13/21 B. Riley
Curis price target raised to $22 from $19 at B. Riley
05/13/21 Cantor Fitzgerald
Curis price target raised to $24 from $15 at Cantor Fitzgerald
05/12/21 Cantor Fitzgerald
Initial look from Curis EHA updates 'very positive,' says Cantor Fitzgerald
XLRN Acceleron
$133.36 /

+2.36 (+1.80%)

06/11/21 H.C. Wainwright
Acceleron results for Phase 2 BEYOND study 'impressive,' says H.C. Wainwright
05/19/21 Piper Sandler
Piper remains bullish on Acceleron after Phase 2 PULSAR OLE, SPECTRA updates
04/26/21 Credit Suisse
Acceleron assumed with an Outperform at Credit Suisse
03/23/21
Fly Intel: Top five analyst downgrades
EPZM Epizyme
$8.53 /

+0.08 (+0.95%)

05/07/21 SVB Leerink
Epizyme upgraded to Outperform from Market Perform at SVB Leerink
04/23/21 Cowen
Epizyme transferred with Outperform at Cowen
03/30/21 Credit Suisse
Epizyme initiated with an Outperform at Credit Suisse
03/30/21 Credit Suisse
Epizyme initiated with an Outperform at Credit Suisse
INCY Incyte
$82.59 /

-4.97 (-5.68%)

02/10/21 SVB Leerink
Incyte downgraded to Market Perform from Outperform at SVB Leerink
01/07/21 Truist
Incyte initiated with a Buy at Truist
01/07/21 Truist
Incyte initiated with a Buy at Truist
01/04/21 Guggenheim
Incyte upgraded to Buy from Neutral at Guggenheim
ORTX Orchard Therapeutics
$5.12 /

-0.05 (-0.97%)

03/10/21 Stifel
Stifel says Bluebird update on AML provides 'some relief' to other LV players
03/02/21 JPMorgan
Orchard Therapeutics assumed with an Overweight at JPMorgan
03/01/21 Stifel
Orchard Therapeutics initiated with a Buy at Stifel
02/18/21 Goldman Sachs
Orchard selloff on Bluebird Bio news overdone, says Goldman Sachs
TGTX TG Therapeutics
$37.81 /

-0.14 (-0.37%)

04/20/21
Fly Intel: Top five analyst initiations
04/20/21 Goldman Sachs
TG Therapeutics initiated with a Neutral at Goldman Sachs
04/19/21 Cantor Fitzgerald
TG Therapeutics price target raised to $74 from $68 at Cantor Fitzgerald
04/19/21 H.C. Wainwright
TG Therapeutics price target raised to $89 from $79 at H.C. Wainwright
EQ Equillium
$6.12 /

-0.85 (-12.20%)

03/03/21
Fly Intel: Top five analyst initiations
03/03/21 JonesTrading
Equillium initiated with a Buy at JonesTrading
11/30/20 H.C. Wainwright
Equillium price target lowered to $12 from $22 at H.C. Wainwright
07/14/20 H.C. Wainwright
Equillium price target raised to $24 from $14 at H.C. Wainwright
JAZZ Jazz Pharmaceuticals
$186.19 /

-0.21 (-0.11%)

05/19/21
Fly Intel: Top five analyst initiations
05/19/21 JPMorgan
Jazz Pharmaceuticals resumed with an Overweight at JPMorgan
05/17/21 H.C. Wainwright
Jazz Pharmaceuticals price target raised to $212 from $207 at H.C. Wainwright
04/21/21 Cantor Fitzgerald
Jazz Pharmaceuticals price target raised to $198 from $185 at Cantor Fitzgerald
VRTX Vertex Pharmaceuticals
$193.02 /

-23.93 (-11.03%)

06/11/21 Roth Capital
Crispr Therapeutics reported 'robust' sickle cell data, says Roth Capital
06/11/21
Fly Intel: Top five analyst downgrades
06/11/21 Stifel
Vertex shares look 'cheap' at aftermarket levels, says Stifel
06/11/21 Cantor Fitzgerald
Vertex Pharmaceuticals price target lowered to $281 from $285 at Cantor Fitzgerald
SGEN Seagen
$156.27 /

-2.3 (-1.45%)

05/17/21 Evercore ISI
Seagen initiated with an In Line at Evercore ISI
04/30/21 Piper Sandler
Seagen price target lowered to $160 from $170 at Piper Sandler
04/12/21 B. Riley
B. Riley calls Agenus the next Seagen, reiterates $8 target
03/30/21 Credit Suisse
Seagen initiated with a Neutral at Credit Suisse
IMRA Imara
$8.56 /

-0.235 (-2.67%)

03/08/21 SVB Leerink
Imara price target lowered to $42 from $59 at SVB Leerink
01/06/21 SVB Leerink
Imara selloff a potential buying opportunity, says SVB Leerink
08/17/20
Fly Intel: Top five analyst upgrades
08/17/20 Citi
Imara upgraded to Buy from Neutral at Citi
GBT Global Blood Therapeutics
$40.64 /

-1.01 (-2.42%)

05/07/21 Cantor Fitzgerald
Global Blood Therapeutics price target lowered to $110 from $120 at Cantor Fitzgerald
05/06/21 Piper Sandler
Global Blood price target lowered to $45 from $50 at Piper Sandler
04/14/21
Fly Intel: Top five analyst initiations
04/14/21 SVB Leerink
SVB Leerink bullish on Global Blood Therapeutics, initiates with an Outperform
BGNE BeiGene
$346.81 /

-6.09 (-1.73%)

03/16/21 HSBC
BeiGene price target raised to $385 from $296 at HSBC
03/08/21 China Renaissance
BeiGene initiated with a Buy at China Renaissance
03/04/21 Goldman Sachs
Five Prime acquisition 'a strategic positive' for Amgen, says Goldman Sachs
03/01/21
Fly Intel: Top five analyst downgrades
APLS Apellis
$62.10 /

+1.33 (+2.19%)

05/20/21 UBS
Apellis initiated with a Buy at UBS
05/18/21 BMO Capital
Apellis price target raised to $68 from $64 at BMO Capital
05/17/21 Oppenheimer
Apellis price target raised to $67 from $64 at Oppenheimer
05/17/21 Raymond James
Apellis price target raised to $115 from $104 at Raymond James
AGIO Agios Pharmaceuticals
$57.80 /

-1.69 (-2.84%)

06/10/21 H.C. Wainwright
Agios Pharmaceuticals initiated with a Buy at H.C. Wainwright
04/30/21 Goldman Sachs
Agios Pharmaceuticals reinstated with a Neutral at Goldman Sachs
04/30/21 Barclays
Agios Pharmaceuticals price target raised to $70 from $65 at Barclays
03/30/21 Piper Sandler
Agios should rally on Forma Therapeutics data, says Piper Sandler
FMTX Forma Therapeutics
$22.81 /

-5.2 (-18.56%)

03/31/21 H.C. Wainwright
Forma Therapeutics price target raised to $55 from $53 at H.C. Wainwright
02/17/21
Fly Intel: Top five analyst initiations
02/17/21 Oppenheimer
Forma Therapeutics initiated with an Outperform at Oppenheimer
KROS Keros Therapeutics
$51.75 /

-0.61 (-1.17%)

12/08/20 SVB Leerink
Keros Therapeutics price target raised to $80 from $42 at SVB Leerink
12/08/20 H.C. Wainwright
Keros Therapeutics price target raised to $100 from $50 at H.C. Wainwright
12/08/20 Piper Sandler
Keros Therapeutics price target raised to $95 from $75 at Piper Sandler
11/18/20 Piper Sandler
Keros Therapeutics price target raised to $75 from $55 at Piper Sandler
CYAD Celyad
$5.75 /

-0.22 (-3.69%)

03/25/21 JonesTrading
Celyad downgraded to Hold from Buy at JonesTrading
12/08/20 H.C. Wainwright
Celyad price target lowered to $18 from $22 at H.C. Wainwright
ALXN Alexion
$181.64 /

-0.41 (-0.23%)

05/05/21
Fly Intel: Top five analyst upgrades
05/05/21 Oppenheimer
Alexion upgraded to Outperform from Perform at Oppenheimer
05/03/21 SVB Leerink
Alexion price target raised to $173 from $156 at SVB Leerink
04/30/21 Wedbush
Alexion's Q1 report 'uneventful' after FTC grants deal clearance, says Wedbush
XLRN Acceleron
$133.36 /

+2.36 (+1.80%)

VRTX Vertex Pharmaceuticals
$193.02 /

-23.93 (-11.03%)

TGTX TG Therapeutics
$37.81 /

-0.14 (-0.37%)

SGEN Seagen
$156.27 /

-2.3 (-1.45%)

RIGL Rigel Pharmaceuticals
$4.02 /

-0.16 (-3.83%)

QURE uniQure
$36.05 /

-0.63 (-1.72%)

ORTX Orchard Therapeutics
$5.12 /

-0.05 (-0.97%)

MGTA Magenta Therapeutics
$11.57 /

-0.15 (-1.28%)

MEIP MEI Pharma
$3.28 /

+0.08 (+2.50%)

MBIO Mustang Bio
$3.79 /

-0.03 (-0.79%)

KROS Keros Therapeutics
$51.75 /

-0.61 (-1.17%)

JAZZ Jazz Pharmaceuticals
$186.19 /

-0.21 (-0.11%)

INCY Incyte
$82.59 /

-4.97 (-5.68%)

IMRA Imara
$8.56 /

-0.235 (-2.67%)

GBT Global Blood Therapeutics
$40.64 /

-1.01 (-2.42%)

FMTX Forma Therapeutics
$22.81 /

-5.2 (-18.56%)

EQ Equillium
$6.12 /

-0.85 (-12.20%)

EPZM Epizyme
$8.53 /

+0.08 (+0.95%)

CRIS Curis
$8.00 /

-4.72 (-37.11%)

BGNE BeiGene
$346.81 /

-6.09 (-1.73%)

APTO Aptose Biosciences
$3.75 /

-1.79 (-32.31%)

APLS Apellis
$62.10 /

+1.33 (+2.19%)

ALXN Alexion
$181.64 /

-0.41 (-0.23%)

AGIO Agios Pharmaceuticals
$57.80 /

-1.69 (-2.84%)

  • 15
    Dec
  • 09
    Dec
  • 11
    Dec
  • 02
    Dec
  • 13
    Nov
  • 14
    Aug
  • 16
    Jul
  • 01
    Jul
  • 25
    Jun
  • 19
    Jun
VRTX Vertex Pharmaceuticals
$193.02 /

-23.93 (-11.03%)

RIGL Rigel Pharmaceuticals
$4.02 /

-0.16 (-3.83%)

ORTX Orchard Therapeutics
$5.12 /

-0.05 (-0.97%)

JAZZ Jazz Pharmaceuticals
$186.19 /

-0.21 (-0.11%)

INCY Incyte
$82.59 /

-4.97 (-5.68%)

EPZM Epizyme
$8.53 /

+0.08 (+0.95%)

VRTX Vertex Pharmaceuticals
$193.02 /

-23.93 (-11.03%)

TGTX TG Therapeutics
$37.81 /

-0.14 (-0.37%)

SGEN Seagen
$156.27 /

-2.3 (-1.45%)

QURE uniQure
$36.05 /

-0.63 (-1.72%)

MBIO Mustang Bio
$3.79 /

-0.03 (-0.79%)

JAZZ Jazz Pharmaceuticals
$186.19 /

-0.21 (-0.11%)

INCY Incyte
$82.59 /

-4.97 (-5.68%)

IMRA Imara
$8.56 /

-0.235 (-2.67%)

GBT Global Blood Therapeutics
$40.64 /

-1.01 (-2.42%)

EQ Equillium
$6.12 /

-0.85 (-12.20%)

CRIS Curis
$8.00 /

-4.72 (-37.11%)

APTO Aptose Biosciences
$3.75 /

-1.79 (-32.31%)

APLS Apellis
$62.10 /

+1.33 (+2.19%)

ALXN Alexion
$181.64 /

-0.41 (-0.23%)

VRTX Vertex Pharmaceuticals
$193.02 /

-23.93 (-11.03%)

INCY Incyte
$82.59 /

-4.97 (-5.68%)

FMTX Forma Therapeutics
$22.81 /

-5.2 (-18.56%)

EQ Equillium
$6.12 /

-0.85 (-12.20%)

CRIS Curis
$8.00 /

-4.72 (-37.11%)

APLS Apellis
$62.10 /

+1.33 (+2.19%)

ALXN Alexion
$181.64 /

-0.41 (-0.23%)

Friday
Conference/Events
European Hematology Association to hold virtual meeting » 04:55
06/11/21
06/11
04:55
06/11/21
04:55
APTO

Aptose Biosciences

$5.54 /

+0.19 (+3.55%)

, MBIO

Mustang Bio

$3.82 /

+0.07 (+1.87%)

, QURE

uniQure

$36.68 /

+0.3 (+0.82%)

, RIGL

Rigel Pharmaceuticals

$4.18 /

+0.09 (+2.20%)

, MGTA

Magenta Therapeutics

$11.71 /

+0.04 (+0.34%)

, MEIP

MEI Pharma

$3.20 /

+0.045 (+1.43%)

, CRIS

Curis

$12.71 /

-0.3 (-2.31%)

, XLRN

Acceleron

$130.95 /

+4.43 (+3.50%)

, EPZM

Epizyme

$8.46 /

-0.015 (-0.18%)

, INCY

Incyte

$87.53 /

+1.3 (+1.51%)

, ORTX

Orchard Therapeutics

$5.17 /

-0.07 (-1.34%)

, TGTX

TG Therapeutics

$37.93 /

+0.63 (+1.69%)

, EQ

Equillium

$6.97 /

-0.2 (-2.79%)

, JAZZ

Jazz Pharmaceuticals

$186.01 /

+4.16 (+2.29%)

, VRTX

Vertex Pharmaceuticals

$216.92 /

+3.43 (+1.61%)

, SGEN

Seagen

$158.57 /

+2.92 (+1.88%)

, IMRA

Imara

$8.79 /

+0.06 (+0.69%)

, GBT

Global Blood Therapeutics

$41.66 /

+1.235 (+3.06%)

, BGNE

BeiGene

$352.81 /

+7.16 (+2.07%)

, APLS

Apellis

$60.92 /

+2.04 (+3.46%)

, AGIO

Agios Pharmaceuticals

$59.49 /

+0.46 (+0.78%)

, FMTX

Forma Therapeutics

$28.00 /

-1.21 (-4.14%)

, KROS

Keros Therapeutics

$52.40 /

+0.21 (+0.40%)

, CYAD

Celyad

$5.99 /

+ (+0.00%)

, ALXN

Alexion

$181.95 /

+2.73 (+1.52%)

EHA 2021 Virtual Congress…

EHA 2021 Virtual Congress to be held on June 9-17. Webcast Link

ShowHide Related Items >><<
XLRN Acceleron
$130.95 /

+4.43 (+3.50%)

VRTX Vertex Pharmaceuticals
$216.92 /

+3.43 (+1.61%)

TGTX TG Therapeutics
$37.93 /

+0.63 (+1.69%)

SGEN Seagen
$158.57 /

+2.92 (+1.88%)

RIGL Rigel Pharmaceuticals
$4.18 /

+0.09 (+2.20%)

QURE uniQure
$36.68 /

+0.3 (+0.82%)

ORTX Orchard Therapeutics
$5.17 /

-0.07 (-1.34%)

MGTA Magenta Therapeutics
$11.71 /

+0.04 (+0.34%)

MEIP MEI Pharma
$3.20 /

+0.045 (+1.43%)

MBIO Mustang Bio
$3.82 /

+0.07 (+1.87%)

KROS Keros Therapeutics
$52.40 /

+0.21 (+0.40%)

JAZZ Jazz Pharmaceuticals
$186.01 /

+4.16 (+2.29%)

INCY Incyte
$87.53 /

+1.3 (+1.51%)

IMRA Imara
$8.79 /

+0.06 (+0.69%)

GBT Global Blood Therapeutics
$41.66 /

+1.235 (+3.06%)

FMTX Forma Therapeutics
$28.00 /

-1.21 (-4.14%)

EQ Equillium
$6.97 /

-0.2 (-2.79%)

EPZM Epizyme
$8.46 /

-0.015 (-0.18%)

CYAD Celyad
$5.99 /

+ (+0.00%)

CRIS Curis
$12.71 /

-0.3 (-2.31%)

BGNE BeiGene
$352.81 /

+7.16 (+2.07%)

APTO Aptose Biosciences
$5.54 /

+0.19 (+3.55%)

APLS Apellis
$60.92 /

+2.04 (+3.46%)

ALXN Alexion
$181.95 /

+2.73 (+1.52%)

AGIO Agios Pharmaceuticals
$59.49 /

+0.46 (+0.78%)

APTO Aptose Biosciences
$5.54 /

+0.19 (+3.55%)

02/22/21 JonesTrading
Aptose Biosciences resumed with a Buy at JonesTrading
10/19/20 Cantor Fitzgerald
Aptose Biosciences initiated with an Overweight at Cantor Fitzgerald
09/22/20 Alliance Global Partners
Aptose Biosciences initiated with a Buy at Alliance Global Partners
09/18/20 Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology
MBIO Mustang Bio
$3.82 /

+0.07 (+1.87%)

05/17/21 BTIG
Mustang Bio initiated with a Buy at BTIG
05/17/21 BTIG
Mustang Bio initiated with a Buy at BTIG
05/12/21 Cantor Fitzgerald
Mustang Bio EHA abstract data 'looks promising,' says Cantor Fitzgerald
12/23/20 B. Riley
Mustang Bio transferred with a Buy at B. Riley Securities
QURE uniQure
$36.68 /

+0.3 (+0.82%)

05/20/21 UBS
uniQure initiated with a Neutral at UBS
05/19/21 H.C. Wainwright
uniQure price target raised to $90 from $80 at H.C. Wainwright
04/26/21 Chardan
Chardan sees 'stock momentum' for uniQure after clinical hold lift
04/26/21 Credit Suisse
uniQure assumed with an Outperform at Credit Suisse
RIGL Rigel Pharmaceuticals
$4.18 /

+0.09 (+2.20%)

05/12/21 Cantor Fitzgerald
Rigel rallying on Curis IRAK4 program data, says Cantor Fitzgerald
04/13/21 Piper Sandler
Rigel results in severe COVID-19 trial 'pretty dramatic,' says Piper Sandler
02/18/21 H.C. Wainwright
Rigel Pharmaceuticals price target raised to $11 from $8 at H.C. Wainwright
02/18/21 Piper Sandler
Rigel share setup 'distinctly positive' after Lilly deal, says Piper Sandler
MGTA Magenta Therapeutics
$11.71 /

+0.04 (+0.34%)

05/18/21 B. Riley
Magenta Therapeutics initiated with a Buy, $21 target at B. Riley
05/17/21 B. Riley
Magenta Therapeutics initiated with a Buy at B. Riley
05/13/21 Mizuho
Magenta Therapeutics price target raised to $17 from $16 at Mizuho
01/07/21
Fly Intel: Top five analyst initiations
MEIP MEI Pharma
$3.20 /

+0.045 (+1.43%)

04/26/21 Wells Fargo
MEI Pharma likely to expand scope of voruciclib development, says Wells Fargo
10/12/20 Brookline
MEI Pharma initiated with a Buy at Brookline
09/22/20 Alliance Global Partners
MEI Pharma initiated with a Buy at Alliance Global Partners
07/06/20 Truist
MEI Pharma price target lowered to $12 from $16 at SunTrust
CRIS Curis
$12.71 /

-0.3 (-2.31%)

05/13/21 B. Riley
Curis price target raised to $22 from $19 at B. Riley
05/13/21 Cantor Fitzgerald
Curis price target raised to $24 from $15 at Cantor Fitzgerald
05/12/21 Cantor Fitzgerald
Initial look from Curis EHA updates 'very positive,' says Cantor Fitzgerald
XLRN Acceleron
$130.95 /

+4.43 (+3.50%)

05/19/21 Piper Sandler
Piper remains bullish on Acceleron after Phase 2 PULSAR OLE, SPECTRA updates
04/26/21 Credit Suisse
Acceleron assumed with an Outperform at Credit Suisse
03/23/21
Fly Intel: Top five analyst downgrades
03/23/21 SVB Leerink
SVB Leerink moving to sidelines on Alexion, five others on industry concerns
EPZM Epizyme
$8.46 /

-0.015 (-0.18%)

05/07/21 SVB Leerink
Epizyme upgraded to Outperform from Market Perform at SVB Leerink
04/23/21 Cowen
Epizyme transferred with Outperform at Cowen
03/30/21 Credit Suisse
Epizyme initiated with an Outperform at Credit Suisse
03/30/21 Credit Suisse
Epizyme initiated with an Outperform at Credit Suisse
INCY Incyte
$87.53 /

+1.3 (+1.51%)

02/10/21 SVB Leerink
Incyte downgraded to Market Perform from Outperform at SVB Leerink
01/07/21 Truist
Incyte initiated with a Buy at Truist
01/07/21 Truist
Incyte initiated with a Buy at Truist
01/04/21 Guggenheim
Incyte upgraded to Buy from Neutral at Guggenheim
ORTX Orchard Therapeutics
$5.17 /

-0.07 (-1.34%)

03/10/21 Stifel
Stifel says Bluebird update on AML provides 'some relief' to other LV players
03/02/21 JPMorgan
Orchard Therapeutics assumed with an Overweight at JPMorgan
03/01/21 Stifel
Orchard Therapeutics initiated with a Buy at Stifel
02/18/21 Goldman Sachs
Orchard selloff on Bluebird Bio news overdone, says Goldman Sachs
TGTX TG Therapeutics
$37.93 /

+0.63 (+1.69%)

04/20/21
Fly Intel: Top five analyst initiations
04/20/21 Goldman Sachs
TG Therapeutics initiated with a Neutral at Goldman Sachs
04/19/21 Cantor Fitzgerald
TG Therapeutics price target raised to $74 from $68 at Cantor Fitzgerald
04/19/21 H.C. Wainwright
TG Therapeutics price target raised to $89 from $79 at H.C. Wainwright
EQ Equillium
$6.97 /

-0.2 (-2.79%)

03/03/21
Fly Intel: Top five analyst initiations
03/03/21 JonesTrading
Equillium initiated with a Buy at JonesTrading
11/30/20 H.C. Wainwright
Equillium price target lowered to $12 from $22 at H.C. Wainwright
07/14/20 H.C. Wainwright
Equillium price target raised to $24 from $14 at H.C. Wainwright
JAZZ Jazz Pharmaceuticals
$186.01 /

+4.16 (+2.29%)

05/19/21
Fly Intel: Top five analyst initiations
05/19/21 JPMorgan
Jazz Pharmaceuticals resumed with an Overweight at JPMorgan
05/17/21 H.C. Wainwright
Jazz Pharmaceuticals price target raised to $212 from $207 at H.C. Wainwright
04/21/21 Cantor Fitzgerald
Jazz Pharmaceuticals price target raised to $198 from $185 at Cantor Fitzgerald
VRTX Vertex Pharmaceuticals
$216.92 /

+3.43 (+1.61%)

04/21/21 Jefferies
Jefferies upgrades Crispr Therapeutics to Buy after Vertex deal renegotiated
04/21/21 Barclays
Crispr Therapeutics price target raised to $160 from $140 at Barclays
04/20/21 Chardan
Amended pact may show Vertex confidence in Crisper program, says Chardan
03/25/21 Citi
Citi likes share setup for Vertex Pharmaceuticals, adds to Focus List
SGEN Seagen
$158.57 /

+2.92 (+1.88%)

05/17/21 Evercore ISI
Seagen initiated with an In Line at Evercore ISI
04/30/21 Piper Sandler
Seagen price target lowered to $160 from $170 at Piper Sandler
04/12/21 B. Riley
B. Riley calls Agenus the next Seagen, reiterates $8 target
03/30/21 Credit Suisse
Seagen initiated with a Neutral at Credit Suisse
IMRA Imara
$8.79 /

+0.06 (+0.69%)

03/08/21 SVB Leerink
Imara price target lowered to $42 from $59 at SVB Leerink
01/06/21 SVB Leerink
Imara selloff a potential buying opportunity, says SVB Leerink
08/17/20
Fly Intel: Top five analyst upgrades
08/17/20 Citi
Imara upgraded to Buy from Neutral at Citi
GBT Global Blood Therapeutics
$41.66 /

+1.235 (+3.06%)

05/07/21 Cantor Fitzgerald
Global Blood Therapeutics price target lowered to $110 from $120 at Cantor Fitzgerald
05/06/21 Piper Sandler
Global Blood price target lowered to $45 from $50 at Piper Sandler
04/14/21
Fly Intel: Top five analyst initiations
04/14/21 SVB Leerink
SVB Leerink bullish on Global Blood Therapeutics, initiates with an Outperform
BGNE BeiGene
$352.81 /

+7.16 (+2.07%)

03/16/21 HSBC
BeiGene price target raised to $385 from $296 at HSBC
03/08/21 China Renaissance
BeiGene initiated with a Buy at China Renaissance
03/04/21 Goldman Sachs
Five Prime acquisition 'a strategic positive' for Amgen, says Goldman Sachs
03/01/21
Fly Intel: Top five analyst downgrades
APLS Apellis
$60.92 /

+2.04 (+3.46%)

05/20/21 UBS
Apellis initiated with a Buy at UBS
05/18/21 BMO Capital
Apellis price target raised to $68 from $64 at BMO Capital
05/17/21 Oppenheimer
Apellis price target raised to $67 from $64 at Oppenheimer
05/17/21 Raymond James
Apellis price target raised to $115 from $104 at Raymond James
AGIO Agios Pharmaceuticals
$59.49 /

+0.46 (+0.78%)

06/10/21 H.C. Wainwright
Agios Pharmaceuticals initiated with a Buy at H.C. Wainwright
04/30/21 Goldman Sachs
Agios Pharmaceuticals reinstated with a Neutral at Goldman Sachs
04/30/21 Barclays
Agios Pharmaceuticals price target raised to $70 from $65 at Barclays
03/30/21 Piper Sandler
Agios should rally on Forma Therapeutics data, says Piper Sandler
FMTX Forma Therapeutics
$28.00 /

-1.21 (-4.14%)

03/31/21 H.C. Wainwright
Forma Therapeutics price target raised to $55 from $53 at H.C. Wainwright
02/17/21
Fly Intel: Top five analyst initiations
02/17/21 Oppenheimer
Forma Therapeutics initiated with an Outperform at Oppenheimer
KROS Keros Therapeutics
$52.40 /

+0.21 (+0.40%)

12/08/20 SVB Leerink
Keros Therapeutics price target raised to $80 from $42 at SVB Leerink
12/08/20 H.C. Wainwright
Keros Therapeutics price target raised to $100 from $50 at H.C. Wainwright
12/08/20 Piper Sandler
Keros Therapeutics price target raised to $95 from $75 at Piper Sandler
11/18/20 Piper Sandler
Keros Therapeutics price target raised to $75 from $55 at Piper Sandler
CYAD Celyad
$5.99 /

+ (+0.00%)

03/25/21 JonesTrading
Celyad downgraded to Hold from Buy at JonesTrading
12/08/20 H.C. Wainwright
Celyad price target lowered to $18 from $22 at H.C. Wainwright
ALXN Alexion
$181.95 /

+2.73 (+1.52%)

05/05/21
Fly Intel: Top five analyst upgrades
05/05/21 Oppenheimer
Alexion upgraded to Outperform from Perform at Oppenheimer
05/03/21 SVB Leerink
Alexion price target raised to $173 from $156 at SVB Leerink
04/30/21 Wedbush
Alexion's Q1 report 'uneventful' after FTC grants deal clearance, says Wedbush
XLRN Acceleron
$130.95 /

+4.43 (+3.50%)

VRTX Vertex Pharmaceuticals
$216.92 /

+3.43 (+1.61%)

TGTX TG Therapeutics
$37.93 /

+0.63 (+1.69%)

SGEN Seagen
$158.57 /

+2.92 (+1.88%)

RIGL Rigel Pharmaceuticals
$4.18 /

+0.09 (+2.20%)

QURE uniQure
$36.68 /

+0.3 (+0.82%)

ORTX Orchard Therapeutics
$5.17 /

-0.07 (-1.34%)

MGTA Magenta Therapeutics
$11.71 /

+0.04 (+0.34%)

MEIP MEI Pharma
$3.20 /

+0.045 (+1.43%)

MBIO Mustang Bio
$3.82 /

+0.07 (+1.87%)

KROS Keros Therapeutics
$52.40 /

+0.21 (+0.40%)

JAZZ Jazz Pharmaceuticals
$186.01 /

+4.16 (+2.29%)

INCY Incyte
$87.53 /

+1.3 (+1.51%)

IMRA Imara
$8.79 /

+0.06 (+0.69%)

GBT Global Blood Therapeutics
$41.66 /

+1.235 (+3.06%)

FMTX Forma Therapeutics
$28.00 /

-1.21 (-4.14%)

EQ Equillium
$6.97 /

-0.2 (-2.79%)

EPZM Epizyme
$8.46 /

-0.015 (-0.18%)

CRIS Curis
$12.71 /

-0.3 (-2.31%)

BGNE BeiGene
$352.81 /

+7.16 (+2.07%)

APTO Aptose Biosciences
$5.54 /

+0.19 (+3.55%)

APLS Apellis
$60.92 /

+2.04 (+3.46%)

ALXN Alexion
$181.95 /

+2.73 (+1.52%)

AGIO Agios Pharmaceuticals
$59.49 /

+0.46 (+0.78%)

  • 15
    Dec
  • 09
    Dec
  • 11
    Dec
  • 02
    Dec
  • 13
    Nov
  • 14
    Aug
  • 16
    Jul
  • 01
    Jul
  • 25
    Jun
  • 19
    Jun
VRTX Vertex Pharmaceuticals
$216.92 /

+3.43 (+1.61%)

RIGL Rigel Pharmaceuticals
$4.18 /

+0.09 (+2.20%)

ORTX Orchard Therapeutics
$5.17 /

-0.07 (-1.34%)

JAZZ Jazz Pharmaceuticals
$186.01 /

+4.16 (+2.29%)

INCY Incyte
$87.53 /

+1.3 (+1.51%)

EPZM Epizyme
$8.46 /

-0.015 (-0.18%)

VRTX Vertex Pharmaceuticals
$216.92 /

+3.43 (+1.61%)

TGTX TG Therapeutics
$37.93 /

+0.63 (+1.69%)

SGEN Seagen
$158.57 /

+2.92 (+1.88%)

QURE uniQure
$36.68 /

+0.3 (+0.82%)

JAZZ Jazz Pharmaceuticals
$186.01 /

+4.16 (+2.29%)

INCY Incyte
$87.53 /

+1.3 (+1.51%)

IMRA Imara
$8.79 /

+0.06 (+0.69%)

GBT Global Blood Therapeutics
$41.66 /

+1.235 (+3.06%)

EQ Equillium
$6.97 /

-0.2 (-2.79%)

CRIS Curis
$12.71 /

-0.3 (-2.31%)

APTO Aptose Biosciences
$5.54 /

+0.19 (+3.55%)

APLS Apellis
$60.92 /

+2.04 (+3.46%)

ALXN Alexion
$181.95 /

+2.73 (+1.52%)

VRTX Vertex Pharmaceuticals
$216.92 /

+3.43 (+1.61%)

TGTX TG Therapeutics
$37.93 /

+0.63 (+1.69%)

INCY Incyte
$87.53 /

+1.3 (+1.51%)

FMTX Forma Therapeutics
$28.00 /

-1.21 (-4.14%)

EQ Equillium
$6.97 /

-0.2 (-2.79%)

CRIS Curis
$12.71 /

-0.3 (-2.31%)

APLS Apellis
$60.92 /

+2.04 (+3.46%)

ALXN Alexion
$181.95 /

+2.73 (+1.52%)

Thursday
Conference/Events
European Hematology Association to hold virtual meeting » 04:55
06/10/21
06/10
04:55
06/10/21
04:55
APTO

Aptose Biosciences

$5.35 /

-0.14 (-2.55%)

, MBIO

Mustang Bio

$3.76 /

+0.005 (+0.13%)

, QURE

uniQure

$36.57 /

-0.37 (-1.00%)

, RIGL

Rigel Pharmaceuticals

$4.09 /

+0.11 (+2.76%)

, MGTA

Magenta Therapeutics

$11.67 /

-0.16 (-1.35%)

, MEIP

MEI Pharma

$3.16 /

+0.045 (+1.44%)

, CRIS

Curis

$13.01 /

-1.04 (-7.40%)

, XLRN

Acceleron

$126.52 /

+1.5 (+1.20%)

, EPZM

Epizyme

$8.47 /

+0.1 (+1.19%)

, INCY

Incyte

$86.23 /

+1.45 (+1.71%)

, ORTX

Orchard Therapeutics

$5.24 /

+0.04 (+0.77%)

, TGTX

TG Therapeutics

$37.33 /

+0.17 (+0.46%)

, EQ

Equillium

$7.11 /

-0.48 (-6.32%)

, JAZZ

Jazz Pharmaceuticals

$181.85 /

+2.82 (+1.58%)

, VRTX

Vertex Pharmaceuticals

$213.67 /

+2.57 (+1.22%)

, SGEN

Seagen

$155.59 /

+0.89 (+0.58%)

, IMRA

Imara

$8.83 /

-0.185 (-2.05%)

, GBT

Global Blood Therapeutics

$40.43 /

-0.475 (-1.16%)

, BGNE

BeiGene

$347.81 /

-1.53 (-0.44%)

, APLS

Apellis

$58.87 /

+0.79 (+1.36%)

, AGIO

Agios Pharmaceuticals

$59.04 /

-1.07 (-1.78%)

, FMTX

Forma Therapeutics

$29.18 /

-1.795 (-5.80%)

, KROS

Keros Therapeutics

$51.31 /

-0.36 (-0.70%)

, CYAD

Celyad

$5.99 /

-0.01 (-0.17%)

, ALXN

Alexion

$179.22 /

+2.59 (+1.47%)

EHA 2021 Virtual Congress…

EHA 2021 Virtual Congress to be held on June 9-17. Webcast Link

ShowHide Related Items >><<
XLRN Acceleron
$126.52 /

+1.5 (+1.20%)

VRTX Vertex Pharmaceuticals
$213.67 /

+2.57 (+1.22%)

TGTX TG Therapeutics
$37.33 /

+0.17 (+0.46%)

SGEN Seagen
$155.59 /

+0.89 (+0.58%)

RIGL Rigel Pharmaceuticals
$4.09 /

+0.11 (+2.76%)

QURE uniQure
$36.57 /

-0.37 (-1.00%)

ORTX Orchard Therapeutics
$5.24 /

+0.04 (+0.77%)

MGTA Magenta Therapeutics
$11.67 /

-0.16 (-1.35%)

MEIP MEI Pharma
$3.16 /

+0.045 (+1.44%)

MBIO Mustang Bio
$3.76 /

+0.005 (+0.13%)

KROS Keros Therapeutics
$51.31 /

-0.36 (-0.70%)

JAZZ Jazz Pharmaceuticals
$181.85 /

+2.82 (+1.58%)

INCY Incyte
$86.23 /

+1.45 (+1.71%)

IMRA Imara
$8.83 /

-0.185 (-2.05%)

GBT Global Blood Therapeutics
$40.43 /

-0.475 (-1.16%)

FMTX Forma Therapeutics
$29.18 /

-1.795 (-5.80%)

EQ Equillium
$7.11 /

-0.48 (-6.32%)

EPZM Epizyme
$8.47 /

+0.1 (+1.19%)

CYAD Celyad
$5.99 /

-0.01 (-0.17%)

CRIS Curis
$13.01 /

-1.04 (-7.40%)

BGNE BeiGene
$347.81 /

-1.53 (-0.44%)

APTO Aptose Biosciences
$5.35 /

-0.14 (-2.55%)

APLS Apellis
$58.87 /

+0.79 (+1.36%)

ALXN Alexion
$179.22 /

+2.59 (+1.47%)

AGIO Agios Pharmaceuticals
$59.04 /

-1.07 (-1.78%)

APTO Aptose Biosciences
$5.35 /

-0.14 (-2.55%)

02/22/21 JonesTrading
Aptose Biosciences resumed with a Buy at JonesTrading
10/19/20 Cantor Fitzgerald
Aptose Biosciences initiated with an Overweight at Cantor Fitzgerald
09/22/20 Alliance Global Partners
Aptose Biosciences initiated with a Buy at Alliance Global Partners
09/18/20 Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology
MBIO Mustang Bio
$3.76 /

+0.005 (+0.13%)

05/17/21 BTIG
Mustang Bio initiated with a Buy at BTIG
05/17/21 BTIG
Mustang Bio initiated with a Buy at BTIG
05/12/21 Cantor Fitzgerald
Mustang Bio EHA abstract data 'looks promising,' says Cantor Fitzgerald
12/23/20 B. Riley
Mustang Bio transferred with a Buy at B. Riley Securities
QURE uniQure
$36.57 /

-0.37 (-1.00%)

05/20/21 UBS
uniQure initiated with a Neutral at UBS
05/19/21 H.C. Wainwright
uniQure price target raised to $90 from $80 at H.C. Wainwright
04/26/21 Chardan
Chardan sees 'stock momentum' for uniQure after clinical hold lift
04/26/21 Credit Suisse
uniQure assumed with an Outperform at Credit Suisse
RIGL Rigel Pharmaceuticals
$4.09 /

+0.11 (+2.76%)

05/12/21 Cantor Fitzgerald
Rigel rallying on Curis IRAK4 program data, says Cantor Fitzgerald
04/13/21 Piper Sandler
Rigel results in severe COVID-19 trial 'pretty dramatic,' says Piper Sandler
02/18/21 H.C. Wainwright
Rigel Pharmaceuticals price target raised to $11 from $8 at H.C. Wainwright
02/18/21 Piper Sandler
Rigel share setup 'distinctly positive' after Lilly deal, says Piper Sandler
MGTA Magenta Therapeutics
$11.67 /

-0.16 (-1.35%)

05/18/21 B. Riley
Magenta Therapeutics initiated with a Buy, $21 target at B. Riley
05/17/21 B. Riley
Magenta Therapeutics initiated with a Buy at B. Riley
05/13/21 Mizuho
Magenta Therapeutics price target raised to $17 from $16 at Mizuho
01/07/21
Fly Intel: Top five analyst initiations
MEIP MEI Pharma
$3.16 /

+0.045 (+1.44%)

04/26/21 Wells Fargo
MEI Pharma likely to expand scope of voruciclib development, says Wells Fargo
10/12/20 Brookline
MEI Pharma initiated with a Buy at Brookline
09/22/20 Alliance Global Partners
MEI Pharma initiated with a Buy at Alliance Global Partners
07/06/20 Truist
MEI Pharma price target lowered to $12 from $16 at SunTrust
CRIS Curis
$13.01 /

-1.04 (-7.40%)

05/13/21 B. Riley
Curis price target raised to $22 from $19 at B. Riley
05/13/21 Cantor Fitzgerald
Curis price target raised to $24 from $15 at Cantor Fitzgerald
05/12/21 Cantor Fitzgerald
Initial look from Curis EHA updates 'very positive,' says Cantor Fitzgerald
XLRN Acceleron
$126.52 /

+1.5 (+1.20%)

05/19/21 Piper Sandler
Piper remains bullish on Acceleron after Phase 2 PULSAR OLE, SPECTRA updates
04/26/21 Credit Suisse
Acceleron assumed with an Outperform at Credit Suisse
03/23/21
Fly Intel: Top five analyst downgrades
03/23/21 SVB Leerink
SVB Leerink moving to sidelines on Alexion, five others on industry concerns
EPZM Epizyme
$8.47 /

+0.1 (+1.19%)

05/07/21 SVB Leerink
Epizyme upgraded to Outperform from Market Perform at SVB Leerink
04/23/21 Cowen
Epizyme transferred with Outperform at Cowen
03/30/21 Credit Suisse
Epizyme initiated with an Outperform at Credit Suisse
03/30/21 Credit Suisse
Epizyme initiated with an Outperform at Credit Suisse
INCY Incyte
$86.23 /

+1.45 (+1.71%)

02/10/21 SVB Leerink
Incyte downgraded to Market Perform from Outperform at SVB Leerink
01/07/21 Truist
Incyte initiated with a Buy at Truist
01/07/21 Truist
Incyte initiated with a Buy at Truist
01/04/21 Guggenheim
Incyte upgraded to Buy from Neutral at Guggenheim
ORTX Orchard Therapeutics
$5.24 /

+0.04 (+0.77%)

03/10/21 Stifel
Stifel says Bluebird update on AML provides 'some relief' to other LV players
03/02/21 JPMorgan
Orchard Therapeutics assumed with an Overweight at JPMorgan
03/01/21 Stifel
Orchard Therapeutics initiated with a Buy at Stifel
02/18/21 Goldman Sachs
Orchard selloff on Bluebird Bio news overdone, says Goldman Sachs
TGTX TG Therapeutics
$37.33 /

+0.17 (+0.46%)

04/20/21
Fly Intel: Top five analyst initiations
04/20/21 Goldman Sachs
TG Therapeutics initiated with a Neutral at Goldman Sachs
04/19/21 Cantor Fitzgerald
TG Therapeutics price target raised to $74 from $68 at Cantor Fitzgerald
04/19/21 H.C. Wainwright
TG Therapeutics price target raised to $89 from $79 at H.C. Wainwright
EQ Equillium
$7.11 /

-0.48 (-6.32%)

03/03/21
Fly Intel: Top five analyst initiations
03/03/21 JonesTrading
Equillium initiated with a Buy at JonesTrading
11/30/20 H.C. Wainwright
Equillium price target lowered to $12 from $22 at H.C. Wainwright
07/14/20 H.C. Wainwright
Equillium price target raised to $24 from $14 at H.C. Wainwright
JAZZ Jazz Pharmaceuticals
$181.85 /

+2.82 (+1.58%)

05/19/21
Fly Intel: Top five analyst initiations
05/19/21 JPMorgan
Jazz Pharmaceuticals resumed with an Overweight at JPMorgan
05/17/21 H.C. Wainwright
Jazz Pharmaceuticals price target raised to $212 from $207 at H.C. Wainwright
04/21/21 Cantor Fitzgerald
Jazz Pharmaceuticals price target raised to $198 from $185 at Cantor Fitzgerald
VRTX Vertex Pharmaceuticals
$213.67 /

+2.57 (+1.22%)

04/21/21 Jefferies
Jefferies upgrades Crispr Therapeutics to Buy after Vertex deal renegotiated
04/21/21 Barclays
Crispr Therapeutics price target raised to $160 from $140 at Barclays
04/20/21 Chardan
Amended pact may show Vertex confidence in Crisper program, says Chardan
03/25/21 Citi
Citi likes share setup for Vertex Pharmaceuticals, adds to Focus List
SGEN Seagen
$155.59 /

+0.89 (+0.58%)

05/17/21 Evercore ISI
Seagen initiated with an In Line at Evercore ISI
04/30/21 Piper Sandler
Seagen price target lowered to $160 from $170 at Piper Sandler
04/12/21 B. Riley
B. Riley calls Agenus the next Seagen, reiterates $8 target
03/30/21 Credit Suisse
Seagen initiated with a Neutral at Credit Suisse
IMRA Imara
$8.83 /

-0.185 (-2.05%)

03/08/21 SVB Leerink
Imara price target lowered to $42 from $59 at SVB Leerink
01/06/21 SVB Leerink
Imara selloff a potential buying opportunity, says SVB Leerink
08/17/20
Fly Intel: Top five analyst upgrades
08/17/20 Citi
Imara upgraded to Buy from Neutral at Citi
GBT Global Blood Therapeutics
$40.43 /

-0.475 (-1.16%)

05/07/21 Cantor Fitzgerald
Global Blood Therapeutics price target lowered to $110 from $120 at Cantor Fitzgerald
05/06/21 Piper Sandler
Global Blood price target lowered to $45 from $50 at Piper Sandler
04/14/21
Fly Intel: Top five analyst initiations
04/14/21 SVB Leerink
SVB Leerink bullish on Global Blood Therapeutics, initiates with an Outperform
BGNE BeiGene
$347.81 /

-1.53 (-0.44%)

03/16/21 HSBC
BeiGene price target raised to $385 from $296 at HSBC
03/08/21 China Renaissance
BeiGene initiated with a Buy at China Renaissance
03/04/21 Goldman Sachs
Five Prime acquisition 'a strategic positive' for Amgen, says Goldman Sachs
03/01/21
Fly Intel: Top five analyst downgrades
APLS Apellis
$58.87 /

+0.79 (+1.36%)

05/20/21 UBS
Apellis initiated with a Buy at UBS
05/18/21 BMO Capital
Apellis price target raised to $68 from $64 at BMO Capital
05/17/21 Oppenheimer
Apellis price target raised to $67 from $64 at Oppenheimer
05/17/21 Raymond James
Apellis price target raised to $115 from $104 at Raymond James
AGIO Agios Pharmaceuticals
$59.04 /

-1.07 (-1.78%)

04/30/21 Goldman Sachs
Agios Pharmaceuticals reinstated with a Neutral at Goldman Sachs
04/30/21 Barclays
Agios Pharmaceuticals price target raised to $70 from $65 at Barclays
03/30/21 Piper Sandler
Agios should rally on Forma Therapeutics data, says Piper Sandler
03/01/21 JPMorgan
JPMorgan downgrades Agios on lack of 'game-changing catalysts'
FMTX Forma Therapeutics
$29.18 /

-1.795 (-5.80%)

03/31/21 H.C. Wainwright
Forma Therapeutics price target raised to $55 from $53 at H.C. Wainwright
02/17/21
Fly Intel: Top five analyst initiations
02/17/21 Oppenheimer
Forma Therapeutics initiated with an Outperform at Oppenheimer
KROS Keros Therapeutics
$51.31 /

-0.36 (-0.70%)

12/08/20 SVB Leerink
Keros Therapeutics price target raised to $80 from $42 at SVB Leerink
12/08/20 H.C. Wainwright
Keros Therapeutics price target raised to $100 from $50 at H.C. Wainwright
12/08/20 Piper Sandler
Keros Therapeutics price target raised to $95 from $75 at Piper Sandler
11/18/20 Piper Sandler
Keros Therapeutics price target raised to $75 from $55 at Piper Sandler
CYAD Celyad
$5.99 /

-0.01 (-0.17%)

03/25/21 JonesTrading
Celyad downgraded to Hold from Buy at JonesTrading
12/08/20 H.C. Wainwright
Celyad price target lowered to $18 from $22 at H.C. Wainwright
ALXN Alexion
$179.22 /

+2.59 (+1.47%)

05/05/21
Fly Intel: Top five analyst upgrades
05/05/21 Oppenheimer
Alexion upgraded to Outperform from Perform at Oppenheimer
05/03/21 SVB Leerink
Alexion price target raised to $173 from $156 at SVB Leerink
04/30/21 Wedbush
Alexion's Q1 report 'uneventful' after FTC grants deal clearance, says Wedbush
XLRN Acceleron
$126.52 /

+1.5 (+1.20%)

VRTX Vertex Pharmaceuticals
$213.67 /

+2.57 (+1.22%)

TGTX TG Therapeutics
$37.33 /

+0.17 (+0.46%)

SGEN Seagen
$155.59 /

+0.89 (+0.58%)

RIGL Rigel Pharmaceuticals
$4.09 /

+0.11 (+2.76%)

QURE uniQure
$36.57 /

-0.37 (-1.00%)

ORTX Orchard Therapeutics
$5.24 /

+0.04 (+0.77%)

MGTA Magenta Therapeutics
$11.67 /

-0.16 (-1.35%)

MEIP MEI Pharma
$3.16 /

+0.045 (+1.44%)

MBIO Mustang Bio
$3.76 /

+0.005 (+0.13%)

KROS Keros Therapeutics
$51.31 /

-0.36 (-0.70%)

JAZZ Jazz Pharmaceuticals
$181.85 /

+2.82 (+1.58%)

INCY Incyte
$86.23 /

+1.45 (+1.71%)

IMRA Imara
$8.83 /

-0.185 (-2.05%)

GBT Global Blood Therapeutics
$40.43 /

-0.475 (-1.16%)

FMTX Forma Therapeutics
$29.18 /

-1.795 (-5.80%)

EQ Equillium
$7.11 /

-0.48 (-6.32%)

EPZM Epizyme
$8.47 /

+0.1 (+1.19%)

CRIS Curis
$13.01 /

-1.04 (-7.40%)

BGNE BeiGene
$347.81 /

-1.53 (-0.44%)

APTO Aptose Biosciences
$5.35 /

-0.14 (-2.55%)

APLS Apellis
$58.87 /

+0.79 (+1.36%)

ALXN Alexion
$179.22 /

+2.59 (+1.47%)

AGIO Agios Pharmaceuticals
$59.04 /

-1.07 (-1.78%)

  • 15
    Dec
  • 09
    Dec
  • 11
    Dec
  • 02
    Dec
  • 13
    Nov
  • 14
    Aug
  • 16
    Jul
  • 01
    Jul
  • 25
    Jun
  • 19
    Jun
  • 11
    Jun
VRTX Vertex Pharmaceuticals
$213.67 /

+2.57 (+1.22%)

RIGL Rigel Pharmaceuticals
$4.09 /

+0.11 (+2.76%)

ORTX Orchard Therapeutics
$5.24 /

+0.04 (+0.77%)

JAZZ Jazz Pharmaceuticals
$181.85 /

+2.82 (+1.58%)

INCY Incyte
$86.23 /

+1.45 (+1.71%)

EPZM Epizyme
$8.47 /

+0.1 (+1.19%)

VRTX Vertex Pharmaceuticals
$213.67 /

+2.57 (+1.22%)

TGTX TG Therapeutics
$37.33 /

+0.17 (+0.46%)

SGEN Seagen
$155.59 /

+0.89 (+0.58%)

QURE uniQure
$36.57 /

-0.37 (-1.00%)

JAZZ Jazz Pharmaceuticals
$181.85 /

+2.82 (+1.58%)

INCY Incyte
$86.23 /

+1.45 (+1.71%)

IMRA Imara
$8.83 /

-0.185 (-2.05%)

GBT Global Blood Therapeutics
$40.43 /

-0.475 (-1.16%)

EQ Equillium
$7.11 /

-0.48 (-6.32%)

CRIS Curis
$13.01 /

-1.04 (-7.40%)

APTO Aptose Biosciences
$5.35 /

-0.14 (-2.55%)

APLS Apellis
$58.87 /

+0.79 (+1.36%)

ALXN Alexion
$179.22 /

+2.59 (+1.47%)

VRTX Vertex Pharmaceuticals
$213.67 /

+2.57 (+1.22%)

TGTX TG Therapeutics
$37.33 /

+0.17 (+0.46%)

INCY Incyte
$86.23 /

+1.45 (+1.71%)

FMTX Forma Therapeutics
$29.18 /

-1.795 (-5.80%)

EQ Equillium
$7.11 /

-0.48 (-6.32%)

CRIS Curis
$13.01 /

-1.04 (-7.40%)

APLS Apellis
$58.87 /

+0.79 (+1.36%)

ALXN Alexion
$179.22 /

+2.59 (+1.47%)

Wednesday
Conference/Events
European Hematology Association to hold virtual meeting » 12:08
06/09/21
06/09
12:08
06/09/21
12:08
AGIO

Agios Pharmaceuticals

$59.27 /

-0.84 (-1.40%)

, ALXN

Alexion

$178.40 /

+1.77 (+1.00%)

, APLS

Apellis

$58.69 /

+0.61 (+1.05%)

, APTO

Aptose Biosciences

$5.44 /

-0.055 (-1.00%)

, AZN

AstraZeneca

$57.21 /

+0.89 (+1.58%)

, BGNE

BeiGene

$350.00 /

+0.66 (+0.19%)

, CRIS

Curis

$13.47 /

-0.58 (-4.13%)

, CYAD

Celyad

$6.11 /

+0.11 (+1.83%)

, EPZM

Epizyme

$8.50 /

+0.13 (+1.55%)

, EQ

Equillium

$7.40 /

-0.19 (-2.50%)

, FMTX

Forma Therapeutics

$30.03 /

-0.94 (-3.04%)

, GBT

Global Blood Therapeutics

$40.53 /

-0.37 (-0.90%)

, IMRA

Imara

$9.20 /

+0.19 (+2.11%)

, INCY

Incyte

$84.85 /

+0.07 (+0.08%)

, JAZZ

Jazz Pharmaceuticals

$183.01 /

+3.98 (+2.22%)

, KROS

Keros Therapeutics

$51.77 /

+0.1 (+0.19%)

, MBIO

Mustang Bio

$3.77 /

+0.015 (+0.40%)

, MEIP

MEI Pharma

$3.17 /

+0.055 (+1.77%)

, MGTA

Magenta Therapeutics

$12.02 /

+0.19 (+1.61%)

, ORTX

Orchard Therapeutics

$5.30 /

+0.1 (+1.92%)

, QURE

uniQure

$37.15 /

+0.21 (+0.57%)

, RIGL

Rigel Pharmaceuticals

$4.11 /

+0.125 (+3.14%)

, SGEN

Seagen

$156.89 /

+2.19 (+1.42%)

, TGTX

TG Therapeutics

$37.19 /

+0.03 (+0.08%)

, VRTX

Vertex Pharmaceuticals

$211.91 /

+0.81 (+0.38%)

, XLRN

Acceleron

$126.11 /

+1.09 (+0.87%)

Virtual Meeting of EHA…

Virtual Meeting of EHA 2021 to be held on June 9-17.Webcast Link

ShowHide Related Items >><<
XLRN Acceleron
$126.11 /

+1.09 (+0.87%)

VRTX Vertex Pharmaceuticals
$211.91 /

+0.81 (+0.38%)

TGTX TG Therapeutics
$37.19 /

+0.03 (+0.08%)

SGEN Seagen
$156.89 /

+2.19 (+1.42%)

RIGL Rigel Pharmaceuticals
$4.11 /

+0.125 (+3.14%)

QURE uniQure
$37.15 /

+0.21 (+0.57%)

ORTX Orchard Therapeutics
$5.30 /

+0.1 (+1.92%)

MGTA Magenta Therapeutics
$12.02 /

+0.19 (+1.61%)

MEIP MEI Pharma
$3.17 /

+0.055 (+1.77%)

MBIO Mustang Bio
$3.77 /

+0.015 (+0.40%)

KROS Keros Therapeutics
$51.77 /

+0.1 (+0.19%)

JAZZ Jazz Pharmaceuticals
$183.01 /

+3.98 (+2.22%)

INCY Incyte
$84.85 /

+0.07 (+0.08%)

IMRA Imara
$9.20 /

+0.19 (+2.11%)

GBT Global Blood Therapeutics
$40.53 /

-0.37 (-0.90%)

FMTX Forma Therapeutics
$30.03 /

-0.94 (-3.04%)

EQ Equillium
$7.40 /

-0.19 (-2.50%)

EPZM Epizyme
$8.50 /

+0.13 (+1.55%)

CYAD Celyad
$6.11 /

+0.11 (+1.83%)

CRIS Curis
$13.47 /

-0.58 (-4.13%)

BGNE BeiGene
$350.00 /

+0.66 (+0.19%)

AZN AstraZeneca
$57.21 /

+0.89 (+1.58%)

APTO Aptose Biosciences
$5.44 /

-0.055 (-1.00%)

APLS Apellis
$58.69 /

+0.61 (+1.05%)

ALXN Alexion
$178.40 /

+1.77 (+1.00%)

AGIO Agios Pharmaceuticals
$59.27 /

-0.84 (-1.40%)

AGIO Agios Pharmaceuticals
$59.27 /

-0.84 (-1.40%)

04/30/21 Goldman Sachs
Agios Pharmaceuticals reinstated with a Neutral at Goldman Sachs
04/30/21 Barclays
Agios Pharmaceuticals price target raised to $70 from $65 at Barclays
03/30/21 Piper Sandler
Agios should rally on Forma Therapeutics data, says Piper Sandler
03/01/21 JPMorgan
JPMorgan downgrades Agios on lack of 'game-changing catalysts'
ALXN Alexion
$178.40 /

+1.77 (+1.00%)

05/05/21
Fly Intel: Top five analyst upgrades
05/05/21 Oppenheimer
Alexion upgraded to Outperform from Perform at Oppenheimer
05/03/21 SVB Leerink
Alexion price target raised to $173 from $156 at SVB Leerink
04/30/21 Wedbush
Alexion's Q1 report 'uneventful' after FTC grants deal clearance, says Wedbush
APLS Apellis
$58.69 /

+0.61 (+1.05%)

05/20/21 UBS
Apellis initiated with a Buy at UBS
05/18/21 BMO Capital
Apellis price target raised to $68 from $64 at BMO Capital
05/17/21 Oppenheimer
Apellis price target raised to $67 from $64 at Oppenheimer
05/17/21 Raymond James
Apellis price target raised to $115 from $104 at Raymond James
APTO Aptose Biosciences
$5.44 /

-0.055 (-1.00%)

02/22/21 JonesTrading
Aptose Biosciences resumed with a Buy at JonesTrading
10/19/20 Cantor Fitzgerald
Aptose Biosciences initiated with an Overweight at Cantor Fitzgerald
09/22/20 Alliance Global Partners
Aptose Biosciences initiated with a Buy at Alliance Global Partners
09/18/20 Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology
AZN AstraZeneca
$57.21 /

+0.89 (+1.58%)

06/01/21 Piper Sandler
Piper sees 'quite real' chance of Akebia's vadadustat being first HIF approved
04/14/21 Guggenheim
Emergent BioSolutions price target lowered to $110 from $130 at Guggenheim
BGNE BeiGene
$350.00 /

+0.66 (+0.19%)

03/16/21 HSBC
BeiGene price target raised to $385 from $296 at HSBC
03/08/21 China Renaissance
BeiGene initiated with a Buy at China Renaissance
03/04/21 Goldman Sachs
Five Prime acquisition 'a strategic positive' for Amgen, says Goldman Sachs
03/01/21
Fly Intel: Top five analyst downgrades
CRIS Curis
$13.47 /

-0.58 (-4.13%)

05/13/21 B. Riley
Curis price target raised to $22 from $19 at B. Riley
05/13/21 Cantor Fitzgerald
Curis price target raised to $24 from $15 at Cantor Fitzgerald
05/12/21 Cantor Fitzgerald
Rigel rallying on Curis IRAK4 program data, says Cantor Fitzgerald
05/12/21 Cantor Fitzgerald
Initial look from Curis EHA updates 'very positive,' says Cantor Fitzgerald
CYAD Celyad
$6.11 /

+0.11 (+1.83%)

03/25/21 JonesTrading
Celyad downgraded to Hold from Buy at JonesTrading
12/08/20 H.C. Wainwright
Celyad price target lowered to $18 from $22 at H.C. Wainwright
EPZM Epizyme
$8.50 /

+0.13 (+1.55%)

05/07/21 SVB Leerink
Epizyme upgraded to Outperform from Market Perform at SVB Leerink
04/23/21 Cowen
Epizyme transferred with Outperform at Cowen
03/30/21 Credit Suisse
Epizyme initiated with an Outperform at Credit Suisse
03/30/21 Credit Suisse
Epizyme initiated with an Outperform at Credit Suisse
EQ Equillium
$7.40 /

-0.19 (-2.50%)

03/03/21
Fly Intel: Top five analyst initiations
03/03/21 JonesTrading
Equillium initiated with a Buy at JonesTrading
11/30/20 H.C. Wainwright
Equillium price target lowered to $12 from $22 at H.C. Wainwright
07/14/20 H.C. Wainwright
Equillium price target raised to $24 from $14 at H.C. Wainwright
FMTX Forma Therapeutics
$30.03 /

-0.94 (-3.04%)

03/31/21 H.C. Wainwright
Forma Therapeutics price target raised to $55 from $53 at H.C. Wainwright
02/17/21
Fly Intel: Top five analyst initiations
02/17/21 Oppenheimer
Forma Therapeutics initiated with an Outperform at Oppenheimer
GBT Global Blood Therapeutics
$40.53 /

-0.37 (-0.90%)

05/07/21 Cantor Fitzgerald
Global Blood Therapeutics price target lowered to $110 from $120 at Cantor Fitzgerald
05/06/21 Piper Sandler
Global Blood price target lowered to $45 from $50 at Piper Sandler
04/14/21
Fly Intel: Top five analyst initiations
04/14/21 SVB Leerink
SVB Leerink bullish on Global Blood Therapeutics, initiates with an Outperform
IMRA Imara
$9.20 /

+0.19 (+2.11%)

03/08/21 SVB Leerink
Imara price target lowered to $42 from $59 at SVB Leerink
01/06/21 SVB Leerink
Imara selloff a potential buying opportunity, says SVB Leerink
08/17/20
Fly Intel: Top five analyst upgrades
08/17/20 Citi
Imara upgraded to Buy from Neutral at Citi
INCY Incyte
$84.85 /

+0.07 (+0.08%)

02/10/21 SVB Leerink
Incyte downgraded to Market Perform from Outperform at SVB Leerink
01/07/21 Truist
Incyte initiated with a Buy at Truist
01/07/21 Truist
Incyte initiated with a Buy at Truist
01/04/21 Guggenheim
Incyte upgraded to Buy from Neutral at Guggenheim
JAZZ Jazz Pharmaceuticals
$183.01 /

+3.98 (+2.22%)

05/19/21
Fly Intel: Top five analyst initiations
05/19/21 JPMorgan
Jazz Pharmaceuticals resumed with an Overweight at JPMorgan
05/17/21 H.C. Wainwright
Jazz Pharmaceuticals price target raised to $212 from $207 at H.C. Wainwright
04/21/21 Cantor Fitzgerald
Jazz Pharmaceuticals price target raised to $198 from $185 at Cantor Fitzgerald
KROS Keros Therapeutics
$51.77 /

+0.1 (+0.19%)

12/08/20 SVB Leerink
Keros Therapeutics price target raised to $80 from $42 at SVB Leerink
12/08/20 H.C. Wainwright
Keros Therapeutics price target raised to $100 from $50 at H.C. Wainwright
12/08/20 Piper Sandler
Keros Therapeutics price target raised to $95 from $75 at Piper Sandler
11/18/20 Piper Sandler
Keros Therapeutics price target raised to $75 from $55 at Piper Sandler
MBIO Mustang Bio
$3.77 /

+0.015 (+0.40%)

05/17/21 BTIG
Mustang Bio initiated with a Buy at BTIG
05/17/21 BTIG
Mustang Bio initiated with a Buy at BTIG
05/12/21 Cantor Fitzgerald
Mustang Bio EHA abstract data 'looks promising,' says Cantor Fitzgerald
12/23/20 B. Riley
Mustang Bio transferred with a Buy at B. Riley Securities
MEIP MEI Pharma
$3.17 /

+0.055 (+1.77%)

04/26/21 Wells Fargo
MEI Pharma likely to expand scope of voruciclib development, says Wells Fargo
10/12/20 Brookline
MEI Pharma initiated with a Buy at Brookline
09/22/20 Alliance Global Partners
MEI Pharma initiated with a Buy at Alliance Global Partners
07/06/20 Truist
MEI Pharma price target lowered to $12 from $16 at SunTrust
MGTA Magenta Therapeutics
$12.02 /

+0.19 (+1.61%)

05/18/21 B. Riley
Magenta Therapeutics initiated with a Buy, $21 target at B. Riley
05/17/21 B. Riley
Magenta Therapeutics initiated with a Buy at B. Riley
05/13/21 Mizuho
Magenta Therapeutics price target raised to $17 from $16 at Mizuho
01/07/21
Fly Intel: Top five analyst initiations
ORTX Orchard Therapeutics
$5.30 /

+0.1 (+1.92%)

03/10/21 Stifel
Stifel says Bluebird update on AML provides 'some relief' to other LV players
03/02/21 JPMorgan
Orchard Therapeutics assumed with an Overweight at JPMorgan
03/01/21 Stifel
Orchard Therapeutics initiated with a Buy at Stifel
02/18/21 Goldman Sachs
Orchard selloff on Bluebird Bio news overdone, says Goldman Sachs
QURE uniQure
$37.15 /

+0.21 (+0.57%)

05/20/21 UBS
uniQure initiated with a Neutral at UBS
05/19/21 H.C. Wainwright
uniQure price target raised to $90 from $80 at H.C. Wainwright
04/26/21 Chardan
Chardan sees 'stock momentum' for uniQure after clinical hold lift
04/26/21 Credit Suisse
uniQure assumed with an Outperform at Credit Suisse
RIGL Rigel Pharmaceuticals
$4.11 /

+0.125 (+3.14%)

04/13/21 Piper Sandler
Rigel results in severe COVID-19 trial 'pretty dramatic,' says Piper Sandler
02/18/21 H.C. Wainwright
Rigel Pharmaceuticals price target raised to $11 from $8 at H.C. Wainwright
02/18/21 Piper Sandler
Rigel share setup 'distinctly positive' after Lilly deal, says Piper Sandler
SGEN Seagen
$156.89 /

+2.19 (+1.42%)

05/17/21 Evercore ISI
Seagen initiated with an In Line at Evercore ISI
04/30/21 Piper Sandler
Seagen price target lowered to $160 from $170 at Piper Sandler
04/12/21 B. Riley
B. Riley calls Agenus the next Seagen, reiterates $8 target
03/30/21 Credit Suisse
Seagen initiated with a Neutral at Credit Suisse
TGTX TG Therapeutics
$37.19 /

+0.03 (+0.08%)

04/20/21
Fly Intel: Top five analyst initiations
04/20/21 Goldman Sachs
TG Therapeutics initiated with a Neutral at Goldman Sachs
04/19/21 Cantor Fitzgerald
TG Therapeutics price target raised to $74 from $68 at Cantor Fitzgerald
04/19/21 H.C. Wainwright
TG Therapeutics price target raised to $89 from $79 at H.C. Wainwright
VRTX Vertex Pharmaceuticals
$211.91 /

+0.81 (+0.38%)

04/21/21 Jefferies
Jefferies upgrades Crispr Therapeutics to Buy after Vertex deal renegotiated
04/21/21 Barclays
Crispr Therapeutics price target raised to $160 from $140 at Barclays
04/20/21 Chardan
Amended pact may show Vertex confidence in Crisper program, says Chardan
03/25/21 Citi
Citi likes share setup for Vertex Pharmaceuticals, adds to Focus List
XLRN Acceleron
$126.11 /

+1.09 (+0.87%)

05/19/21 Piper Sandler
Piper remains bullish on Acceleron after Phase 2 PULSAR OLE, SPECTRA updates
04/26/21 Credit Suisse
Acceleron assumed with an Outperform at Credit Suisse
03/23/21
Fly Intel: Top five analyst downgrades
03/23/21 SVB Leerink
SVB Leerink moving to sidelines on Alexion, five others on industry concerns
XLRN Acceleron
$126.11 /

+1.09 (+0.87%)

VRTX Vertex Pharmaceuticals
$211.91 /

+0.81 (+0.38%)

TGTX TG Therapeutics
$37.19 /

+0.03 (+0.08%)

SGEN Seagen
$156.89 /

+2.19 (+1.42%)

RIGL Rigel Pharmaceuticals
$4.11 /

+0.125 (+3.14%)

QURE uniQure
$37.15 /

+0.21 (+0.57%)

ORTX Orchard Therapeutics
$5.30 /

+0.1 (+1.92%)

MGTA Magenta Therapeutics
$12.02 /

+0.19 (+1.61%)

MEIP MEI Pharma
$3.17 /

+0.055 (+1.77%)

MBIO Mustang Bio
$3.77 /

+0.015 (+0.40%)

KROS Keros Therapeutics
$51.77 /

+0.1 (+0.19%)

JAZZ Jazz Pharmaceuticals
$183.01 /

+3.98 (+2.22%)

INCY Incyte
$84.85 /

+0.07 (+0.08%)

IMRA Imara
$9.20 /

+0.19 (+2.11%)

GBT Global Blood Therapeutics
$40.53 /

-0.37 (-0.90%)

FMTX Forma Therapeutics
$30.03 /

-0.94 (-3.04%)

EQ Equillium
$7.40 /

-0.19 (-2.50%)

EPZM Epizyme
$8.50 /

+0.13 (+1.55%)

CRIS Curis
$13.47 /

-0.58 (-4.13%)

BGNE BeiGene
$350.00 /

+0.66 (+0.19%)

AZN AstraZeneca
$57.21 /

+0.89 (+1.58%)

APTO Aptose Biosciences
$5.44 /

-0.055 (-1.00%)

APLS Apellis
$58.69 /

+0.61 (+1.05%)

ALXN Alexion
$178.40 /

+1.77 (+1.00%)

AGIO Agios Pharmaceuticals
$59.27 /

-0.84 (-1.40%)

  • 15
    Dec
  • 09
    Dec
  • 11
    Dec
  • 02
    Dec
  • 13
    Nov
  • 14
    Aug
  • 16
    Jul
  • 01
    Jul
  • 25
    Jun
  • 19
    Jun
  • 11
    Jun
VRTX Vertex Pharmaceuticals
$211.91 /

+0.81 (+0.38%)

RIGL Rigel Pharmaceuticals
$4.11 /

+0.125 (+3.14%)

ORTX Orchard Therapeutics
$5.30 /

+0.1 (+1.92%)

JAZZ Jazz Pharmaceuticals
$183.01 /

+3.98 (+2.22%)

INCY Incyte
$84.85 /

+0.07 (+0.08%)

EPZM Epizyme
$8.50 /

+0.13 (+1.55%)

AZN AstraZeneca
$57.21 /

+0.89 (+1.58%)

VRTX Vertex Pharmaceuticals
$211.91 /

+0.81 (+0.38%)

TGTX TG Therapeutics
$37.19 /

+0.03 (+0.08%)

SGEN Seagen
$156.89 /

+2.19 (+1.42%)

QURE uniQure
$37.15 /

+0.21 (+0.57%)

JAZZ Jazz Pharmaceuticals
$183.01 /

+3.98 (+2.22%)

INCY Incyte
$84.85 /

+0.07 (+0.08%)

IMRA Imara
$9.20 /

+0.19 (+2.11%)

GBT Global Blood Therapeutics
$40.53 /

-0.37 (-0.90%)

EQ Equillium
$7.40 /

-0.19 (-2.50%)

CRIS Curis
$13.47 /

-0.58 (-4.13%)

AZN AstraZeneca
$57.21 /

+0.89 (+1.58%)

APTO Aptose Biosciences
$5.44 /

-0.055 (-1.00%)

APLS Apellis
$58.69 /

+0.61 (+1.05%)

ALXN Alexion
$178.40 /

+1.77 (+1.00%)

VRTX Vertex Pharmaceuticals
$211.91 /

+0.81 (+0.38%)

TGTX TG Therapeutics
$37.19 /

+0.03 (+0.08%)

INCY Incyte
$84.85 /

+0.07 (+0.08%)

FMTX Forma Therapeutics
$30.03 /

-0.94 (-3.04%)

EQ Equillium
$7.40 /

-0.19 (-2.50%)

CRIS Curis
$13.47 /

-0.58 (-4.13%)

AZN AstraZeneca
$57.21 /

+0.89 (+1.58%)

APLS Apellis
$58.69 /

+0.61 (+1.05%)

ALXN Alexion
$178.40 /

+1.77 (+1.00%)

Conference/Events
European Hematology Association to hold virtual meeting » 10:55
06/09/21
06/09
10:55
06/09/21
10:55
APTO

Aptose Biosciences

$5.52 /

+0.03 (+0.55%)

, MBIO

Mustang Bio

$3.81 /

+0.055 (+1.46%)

, QURE

uniQure

$37.10 /

+0.16 (+0.43%)

, RIGL

Rigel Pharmaceuticals

$4.10 /

+0.12 (+3.02%)

, MGTA

Magenta Therapeutics

$12.16 /

+0.33 (+2.79%)

, MEIP

MEI Pharma

$3.17 /

+0.055 (+1.77%)

, CRIS

Curis

$14.09 /

+0.04 (+0.28%)

, XLRN

Acceleron

$127.24 /

+2.22 (+1.78%)

, EPZM

Epizyme

$8.52 /

+0.15 (+1.79%)

, INCY

Incyte

$85.44 /

+0.66 (+0.78%)

, ORTX

Orchard Therapeutics

$5.49 /

+0.29 (+5.58%)

, TGTX

TG Therapeutics

$37.25 /

+0.09 (+0.24%)

, EQ

Equillium

$7.56 /

-0.03 (-0.40%)

, JAZZ

Jazz Pharmaceuticals

$181.71 /

+2.68 (+1.50%)

, VRTX

Vertex Pharmaceuticals

$214.60 /

+3.5 (+1.66%)

, SGEN

Seagen

$157.95 /

+3.25 (+2.10%)

, IMRA

Imara

$9.23 /

+0.22 (+2.44%)

, GBT

Global Blood Therapeutics

$41.56 /

+0.66 (+1.61%)

, BGNE

BeiGene

$352.55 /

+3.21 (+0.92%)

, APLS

Apellis

$58.33 /

+0.25 (+0.43%)

, AGIO

Agios Pharmaceuticals

$60.03 /

-0.08 (-0.13%)

, FMTX

Forma Therapeutics

$30.14 /

-0.83 (-2.68%)

, KROS

Keros Therapeutics

$52.06 /

+0.39 (+0.75%)

, CYAD

Celyad

$6.11 /

+0.11 (+1.83%)

, ALXN

Alexion

$179.34 /

+2.71 (+1.53%)

EHA 2021 Virtual Congress…

EHA 2021 Virtual Congress to be held on June 9-17. Webcast Link

ShowHide Related Items >><<
XLRN Acceleron
$127.24 /

+2.22 (+1.78%)

VRTX Vertex Pharmaceuticals
$214.60 /

+3.5 (+1.66%)

TGTX TG Therapeutics
$37.25 /

+0.09 (+0.24%)

SGEN Seagen
$157.95 /

+3.25 (+2.10%)

RIGL Rigel Pharmaceuticals
$4.10 /

+0.12 (+3.02%)

QURE uniQure
$37.10 /

+0.16 (+0.43%)

ORTX Orchard Therapeutics
$5.49 /

+0.29 (+5.58%)

MGTA Magenta Therapeutics
$12.16 /

+0.33 (+2.79%)

MEIP MEI Pharma
$3.17 /

+0.055 (+1.77%)

MBIO Mustang Bio
$3.81 /

+0.055 (+1.46%)

KROS Keros Therapeutics
$52.06 /

+0.39 (+0.75%)

JAZZ Jazz Pharmaceuticals
$181.71 /

+2.68 (+1.50%)

INCY Incyte
$85.44 /

+0.66 (+0.78%)

IMRA Imara
$9.23 /

+0.22 (+2.44%)

GBT Global Blood Therapeutics
$41.56 /

+0.66 (+1.61%)

FMTX Forma Therapeutics
$30.14 /

-0.83 (-2.68%)

EQ Equillium
$7.56 /

-0.03 (-0.40%)

EPZM Epizyme
$8.52 /

+0.15 (+1.79%)

CYAD Celyad
$6.11 /

+0.11 (+1.83%)

CRIS Curis
$14.09 /

+0.04 (+0.28%)

BGNE BeiGene
$352.55 /

+3.21 (+0.92%)

APTO Aptose Biosciences
$5.52 /

+0.03 (+0.55%)

APLS Apellis
$58.33 /

+0.25 (+0.43%)

ALXN Alexion
$179.34 /

+2.71 (+1.53%)

AGIO Agios Pharmaceuticals
$60.03 /

-0.08 (-0.13%)

APTO Aptose Biosciences
$5.52 /

+0.03 (+0.55%)

02/22/21 JonesTrading
Aptose Biosciences resumed with a Buy at JonesTrading
10/19/20 Cantor Fitzgerald
Aptose Biosciences initiated with an Overweight at Cantor Fitzgerald
09/22/20 Alliance Global Partners
Aptose Biosciences initiated with a Buy at Alliance Global Partners
09/18/20 Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology
MBIO Mustang Bio
$3.81 /

+0.055 (+1.46%)

05/17/21 BTIG
Mustang Bio initiated with a Buy at BTIG
05/17/21 BTIG
Mustang Bio initiated with a Buy at BTIG
05/12/21 Cantor Fitzgerald
Mustang Bio EHA abstract data 'looks promising,' says Cantor Fitzgerald
12/23/20 B. Riley
Mustang Bio transferred with a Buy at B. Riley Securities
QURE uniQure
$37.10 /

+0.16 (+0.43%)

05/20/21 UBS
uniQure initiated with a Neutral at UBS
05/19/21 H.C. Wainwright
uniQure price target raised to $90 from $80 at H.C. Wainwright
04/26/21 Chardan
Chardan sees 'stock momentum' for uniQure after clinical hold lift
04/26/21 Credit Suisse
uniQure assumed with an Outperform at Credit Suisse
RIGL Rigel Pharmaceuticals
$4.10 /

+0.12 (+3.02%)

05/12/21 Cantor Fitzgerald
Rigel rallying on Curis IRAK4 program data, says Cantor Fitzgerald
04/13/21 Piper Sandler
Rigel results in severe COVID-19 trial 'pretty dramatic,' says Piper Sandler
02/18/21 H.C. Wainwright
Rigel Pharmaceuticals price target raised to $11 from $8 at H.C. Wainwright
02/18/21 Piper Sandler
Rigel share setup 'distinctly positive' after Lilly deal, says Piper Sandler
MGTA Magenta Therapeutics
$12.16 /

+0.33 (+2.79%)

05/18/21 B. Riley
Magenta Therapeutics initiated with a Buy, $21 target at B. Riley
05/17/21 B. Riley
Magenta Therapeutics initiated with a Buy at B. Riley
05/13/21 Mizuho
Magenta Therapeutics price target raised to $17 from $16 at Mizuho
01/07/21
Fly Intel: Top five analyst initiations
MEIP MEI Pharma
$3.17 /

+0.055 (+1.77%)

04/26/21 Wells Fargo
MEI Pharma likely to expand scope of voruciclib development, says Wells Fargo
10/12/20 Brookline
MEI Pharma initiated with a Buy at Brookline
09/22/20 Alliance Global Partners
MEI Pharma initiated with a Buy at Alliance Global Partners
07/06/20 Truist
MEI Pharma price target lowered to $12 from $16 at SunTrust
CRIS Curis
$14.09 /

+0.04 (+0.28%)

05/13/21 B. Riley
Curis price target raised to $22 from $19 at B. Riley
05/13/21 Cantor Fitzgerald
Curis price target raised to $24 from $15 at Cantor Fitzgerald
05/12/21 Cantor Fitzgerald
Initial look from Curis EHA updates 'very positive,' says Cantor Fitzgerald
XLRN Acceleron
$127.24 /

+2.22 (+1.78%)

05/19/21 Piper Sandler
Piper remains bullish on Acceleron after Phase 2 PULSAR OLE, SPECTRA updates
04/26/21 Credit Suisse
Acceleron assumed with an Outperform at Credit Suisse
03/23/21
Fly Intel: Top five analyst downgrades
03/23/21 SVB Leerink
SVB Leerink moving to sidelines on Alexion, five others on industry concerns
EPZM Epizyme
$8.52 /

+0.15 (+1.79%)

05/07/21 SVB Leerink
Epizyme upgraded to Outperform from Market Perform at SVB Leerink
04/23/21 Cowen
Epizyme transferred with Outperform at Cowen
03/30/21 Credit Suisse
Epizyme initiated with an Outperform at Credit Suisse
03/30/21 Credit Suisse
Epizyme initiated with an Outperform at Credit Suisse
INCY Incyte
$85.44 /

+0.66 (+0.78%)

02/10/21 SVB Leerink
Incyte downgraded to Market Perform from Outperform at SVB Leerink
01/07/21 Truist
Incyte initiated with a Buy at Truist
01/07/21 Truist
Incyte initiated with a Buy at Truist
01/04/21 Guggenheim
Incyte upgraded to Buy from Neutral at Guggenheim
ORTX Orchard Therapeutics
$5.49 /

+0.29 (+5.58%)

03/10/21 Stifel
Stifel says Bluebird update on AML provides 'some relief' to other LV players
03/02/21 JPMorgan
Orchard Therapeutics assumed with an Overweight at JPMorgan
03/01/21 Stifel
Orchard Therapeutics initiated with a Buy at Stifel
02/18/21 Goldman Sachs
Orchard selloff on Bluebird Bio news overdone, says Goldman Sachs
TGTX TG Therapeutics
$37.25 /

+0.09 (+0.24%)

04/20/21
Fly Intel: Top five analyst initiations
04/20/21 Goldman Sachs
TG Therapeutics initiated with a Neutral at Goldman Sachs
04/19/21 Cantor Fitzgerald
TG Therapeutics price target raised to $74 from $68 at Cantor Fitzgerald
04/19/21 H.C. Wainwright
TG Therapeutics price target raised to $89 from $79 at H.C. Wainwright
EQ Equillium
$7.56 /

-0.03 (-0.40%)

03/03/21
Fly Intel: Top five analyst initiations
03/03/21 JonesTrading
Equillium initiated with a Buy at JonesTrading
11/30/20 H.C. Wainwright
Equillium price target lowered to $12 from $22 at H.C. Wainwright
07/14/20 H.C. Wainwright
Equillium price target raised to $24 from $14 at H.C. Wainwright
JAZZ Jazz Pharmaceuticals
$181.71 /

+2.68 (+1.50%)

05/19/21
Fly Intel: Top five analyst initiations
05/19/21 JPMorgan
Jazz Pharmaceuticals resumed with an Overweight at JPMorgan
05/17/21 H.C. Wainwright
Jazz Pharmaceuticals price target raised to $212 from $207 at H.C. Wainwright
04/21/21 Cantor Fitzgerald
Jazz Pharmaceuticals price target raised to $198 from $185 at Cantor Fitzgerald
VRTX Vertex Pharmaceuticals
$214.60 /

+3.5 (+1.66%)

04/21/21 Jefferies
Jefferies upgrades Crispr Therapeutics to Buy after Vertex deal renegotiated
04/21/21 Barclays
Crispr Therapeutics price target raised to $160 from $140 at Barclays
04/20/21 Chardan
Amended pact may show Vertex confidence in Crisper program, says Chardan
03/25/21 Citi
Citi likes share setup for Vertex Pharmaceuticals, adds to Focus List
SGEN Seagen
$157.95 /

+3.25 (+2.10%)

05/17/21 Evercore ISI
Seagen initiated with an In Line at Evercore ISI
04/30/21 Piper Sandler
Seagen price target lowered to $160 from $170 at Piper Sandler
04/12/21 B. Riley
B. Riley calls Agenus the next Seagen, reiterates $8 target
03/30/21 Credit Suisse
Seagen initiated with a Neutral at Credit Suisse
IMRA Imara
$9.23 /

+0.22 (+2.44%)

03/08/21 SVB Leerink
Imara price target lowered to $42 from $59 at SVB Leerink
01/06/21 SVB Leerink
Imara selloff a potential buying opportunity, says SVB Leerink
08/17/20
Fly Intel: Top five analyst upgrades
08/17/20 Citi
Imara upgraded to Buy from Neutral at Citi
GBT Global Blood Therapeutics
$41.56 /

+0.66 (+1.61%)

05/07/21 Cantor Fitzgerald
Global Blood Therapeutics price target lowered to $110 from $120 at Cantor Fitzgerald
05/06/21 Piper Sandler
Global Blood price target lowered to $45 from $50 at Piper Sandler
04/14/21
Fly Intel: Top five analyst initiations
04/14/21 SVB Leerink
SVB Leerink bullish on Global Blood Therapeutics, initiates with an Outperform
BGNE BeiGene
$352.55 /

+3.21 (+0.92%)

03/16/21 HSBC
BeiGene price target raised to $385 from $296 at HSBC
03/08/21 China Renaissance
BeiGene initiated with a Buy at China Renaissance
03/04/21 Goldman Sachs
Five Prime acquisition 'a strategic positive' for Amgen, says Goldman Sachs
03/01/21
Fly Intel: Top five analyst downgrades
APLS Apellis
$58.33 /

+0.25 (+0.43%)

05/20/21 UBS
Apellis initiated with a Buy at UBS
05/18/21 BMO Capital
Apellis price target raised to $68 from $64 at BMO Capital
05/17/21 Oppenheimer
Apellis price target raised to $67 from $64 at Oppenheimer
05/17/21 Raymond James
Apellis price target raised to $115 from $104 at Raymond James
AGIO Agios Pharmaceuticals
$60.03 /

-0.08 (-0.13%)

04/30/21 Goldman Sachs
Agios Pharmaceuticals reinstated with a Neutral at Goldman Sachs
04/30/21 Barclays
Agios Pharmaceuticals price target raised to $70 from $65 at Barclays
03/30/21 Piper Sandler
Agios should rally on Forma Therapeutics data, says Piper Sandler
03/01/21 JPMorgan
JPMorgan downgrades Agios on lack of 'game-changing catalysts'
FMTX Forma Therapeutics
$30.14 /

-0.83 (-2.68%)

03/31/21 H.C. Wainwright
Forma Therapeutics price target raised to $55 from $53 at H.C. Wainwright
02/17/21
Fly Intel: Top five analyst initiations
02/17/21 Oppenheimer
Forma Therapeutics initiated with an Outperform at Oppenheimer
KROS Keros Therapeutics
$52.06 /

+0.39 (+0.75%)

12/08/20 SVB Leerink
Keros Therapeutics price target raised to $80 from $42 at SVB Leerink
12/08/20 H.C. Wainwright
Keros Therapeutics price target raised to $100 from $50 at H.C. Wainwright
12/08/20 Piper Sandler
Keros Therapeutics price target raised to $95 from $75 at Piper Sandler
11/18/20 Piper Sandler
Keros Therapeutics price target raised to $75 from $55 at Piper Sandler
CYAD Celyad
$6.11 /

+0.11 (+1.83%)

03/25/21 JonesTrading
Celyad downgraded to Hold from Buy at JonesTrading
12/08/20 H.C. Wainwright
Celyad price target lowered to $18 from $22 at H.C. Wainwright
ALXN Alexion
$179.34 /

+2.71 (+1.53%)

05/05/21
Fly Intel: Top five analyst upgrades
05/05/21 Oppenheimer
Alexion upgraded to Outperform from Perform at Oppenheimer
05/03/21 SVB Leerink
Alexion price target raised to $173 from $156 at SVB Leerink
04/30/21 Wedbush
Alexion's Q1 report 'uneventful' after FTC grants deal clearance, says Wedbush
XLRN Acceleron
$127.24 /

+2.22 (+1.78%)

VRTX Vertex Pharmaceuticals
$214.60 /

+3.5 (+1.66%)

TGTX TG Therapeutics
$37.25 /

+0.09 (+0.24%)

SGEN Seagen
$157.95 /

+3.25 (+2.10%)

RIGL Rigel Pharmaceuticals
$4.10 /

+0.12 (+3.02%)

QURE uniQure
$37.10 /

+0.16 (+0.43%)

ORTX Orchard Therapeutics
$5.49 /

+0.29 (+5.58%)

MGTA Magenta Therapeutics
$12.16 /

+0.33 (+2.79%)

MEIP MEI Pharma
$3.17 /

+0.055 (+1.77%)

MBIO Mustang Bio
$3.81 /

+0.055 (+1.46%)

KROS Keros Therapeutics
$52.06 /

+0.39 (+0.75%)

JAZZ Jazz Pharmaceuticals
$181.71 /

+2.68 (+1.50%)

INCY Incyte
$85.44 /

+0.66 (+0.78%)

IMRA Imara
$9.23 /

+0.22 (+2.44%)

GBT Global Blood Therapeutics
$41.56 /

+0.66 (+1.61%)

FMTX Forma Therapeutics
$30.14 /

-0.83 (-2.68%)

EQ Equillium
$7.56 /

-0.03 (-0.40%)

EPZM Epizyme
$8.52 /

+0.15 (+1.79%)

CRIS Curis
$14.09 /

+0.04 (+0.28%)

BGNE BeiGene
$352.55 /

+3.21 (+0.92%)

APTO Aptose Biosciences
$5.52 /

+0.03 (+0.55%)

APLS Apellis
$58.33 /

+0.25 (+0.43%)

ALXN Alexion
$179.34 /

+2.71 (+1.53%)

AGIO Agios Pharmaceuticals
$60.03 /

-0.08 (-0.13%)

  • 15
    Dec
  • 09
    Dec
  • 11
    Dec
  • 02
    Dec
  • 13
    Nov
  • 14
    Aug
  • 16
    Jul
  • 01
    Jul
  • 25
    Jun
  • 19
    Jun
  • 11
    Jun
VRTX Vertex Pharmaceuticals
$214.60 /

+3.5 (+1.66%)

RIGL Rigel Pharmaceuticals
$4.10 /

+0.12 (+3.02%)

ORTX Orchard Therapeutics
$5.49 /

+0.29 (+5.58%)

JAZZ Jazz Pharmaceuticals
$181.71 /

+2.68 (+1.50%)

INCY Incyte
$85.44 /

+0.66 (+0.78%)

EPZM Epizyme
$8.52 /

+0.15 (+1.79%)

VRTX Vertex Pharmaceuticals
$214.60 /

+3.5 (+1.66%)

TGTX TG Therapeutics
$37.25 /

+0.09 (+0.24%)

SGEN Seagen
$157.95 /

+3.25 (+2.10%)

QURE uniQure
$37.10 /

+0.16 (+0.43%)

JAZZ Jazz Pharmaceuticals
$181.71 /

+2.68 (+1.50%)

INCY Incyte
$85.44 /

+0.66 (+0.78%)

IMRA Imara
$9.23 /

+0.22 (+2.44%)

GBT Global Blood Therapeutics
$41.56 /

+0.66 (+1.61%)

EQ Equillium
$7.56 /

-0.03 (-0.40%)

CRIS Curis
$14.09 /

+0.04 (+0.28%)

APTO Aptose Biosciences
$5.52 /

+0.03 (+0.55%)

APLS Apellis
$58.33 /

+0.25 (+0.43%)

ALXN Alexion
$179.34 /

+2.71 (+1.53%)

VRTX Vertex Pharmaceuticals
$214.60 /

+3.5 (+1.66%)

TGTX TG Therapeutics
$37.25 /

+0.09 (+0.24%)

INCY Incyte
$85.44 /

+0.66 (+0.78%)

FMTX Forma Therapeutics
$30.14 /

-0.83 (-2.68%)

EQ Equillium
$7.56 /

-0.03 (-0.40%)

CRIS Curis
$14.09 /

+0.04 (+0.28%)

APLS Apellis
$58.33 /

+0.25 (+0.43%)

ALXN Alexion
$179.34 /

+2.71 (+1.53%)

Monday
Hot Stocks
SpringsWorks, Seagen enter collaboration for nirogacestat w/ SEA-BCMA » 06:42
06/07/21
06/07
06:42
06/07/21
06:42
SWTX

SpringsWorks Therapeutics

$78.83 /

+2.05 (+2.67%)

, SGEN

Seagen

$148.21 /

+1.08 (+0.73%)

SpringWorks Therapeutics…

SpringWorks Therapeutics (SWTX) announced that the company has entered into a clinical trial collaboration agreement with Seagen (SGEN) to evaluate nirogacestat, SpringWorks' investigational gamma secretase inhibitor, in combination with SEA-BCMA, Seagen's investigational monoclonal antibody targeting B-cell maturation agent, in patients with relapsed or refractory multiple myeloma. Gamma secretase inhibition prevents the cleavage and shedding of BCMA from the surface of myeloma cells. In preclinical models, nirogacestat has been shown to increase levels of membrane-bound BCMA and reduce levels of soluble BCMA, thereby enhancing the activity of BCMA-targeted therapies. Under the terms of the agreement, Seagen will sponsor and conduct the Phase 1 study to evaluate the safety, tolerability and preliminary efficacy of the combination, and will assume all costs associated with the study, other than expenses related to the manufacturing of nirogacestat and certain expenses related to intellectual property rights. Seagen and SpringWorks will also form a joint development committee to manage the clinical study, which is expected to commence in the second half of 2021. In addition to its ongoing clinical collaborations with BCMA-directed therapies, SpringWorks is conducting a global Phase 3, double-blind, randomized, placebo-controlled clinical trial to evaluate nirogacestat as a monotherapy in adults with progressing desmoid tumors.

ShowHide Related Items >><<
SWTX SpringsWorks Therapeutics
$78.83 /

+2.05 (+2.67%)

SGEN Seagen
$148.21 /

+1.08 (+0.73%)

SWTX SpringsWorks Therapeutics
$78.83 /

+2.05 (+2.67%)

03/30/21 JPMorgan
SpringsWorks Therapeutics added to Analyst Focus List at JPMorgan
02/26/21 Barclays
SpringsWorks Therapeutics price target raised to $105 from $92 at Barclays
02/25/21 H.C. Wainwright
SpringsWorks price target raised to $124 from $101 at H.C. Wainwright
01/22/21 Barclays
SpringsWorks Therapeutics price target raised to $92 from $83 at Barclays
SGEN Seagen
$148.21 /

+1.08 (+0.73%)

05/17/21 Evercore ISI
Seagen initiated with an In Line at Evercore ISI
04/30/21 Piper Sandler
Seagen price target lowered to $160 from $170 at Piper Sandler
04/12/21 B. Riley
B. Riley calls Agenus the next Seagen, reiterates $8 target
03/30/21 Credit Suisse
Seagen initiated with a Neutral at Credit Suisse
SWTX SpringsWorks Therapeutics
$78.83 /

+2.05 (+2.67%)

SGEN Seagen
$148.21 /

+1.08 (+0.73%)

  • 02
    Mar
  • 08
    Oct
SGEN Seagen
$148.21 /

+1.08 (+0.73%)

SWTX SpringsWorks Therapeutics
$78.83 /

+2.05 (+2.67%)

Over a week ago
Hot Stocks
Seagen's Tukysa combination shows improved survival in breast cancer » 06:06
06/03/21
06/03
06:06
06/03/21
06:06
SGEN

Seagen

$148.11 /

-5.87 (-3.81%)

Seagen announced that…

Seagen announced that improvements in overall survival and progression-free survival were maintained with long-term follow up from the pivotal HER2CLIMB trial evaluating the addition of Tukysa - tucatinib - to trastuzumab and capecitabine in patients with HER2-positive metastatic breast cancer with and without brain metastases. Data from the pre-specified exploratory analysis will be presented at the 2021 American Society of Clinical Oncology Annual Meeting. The overall survival benefit seen with Tukysa at the time of the primary analysis was maintained after an additional 15.6 months of follow-up - total of 29.6 months -, demonstrating a 5.5-month improvement in median OS for the Tukysa regimen vs. 19.2 months for capecitabine and trastuzumab alone. This benefit continued to be generally consistent across pre-specified patient subgroups. Median OS in the Tukysa arm was 24.7 months vs. median OS of 19.2 months in the control arm. Median PFS in the Tukysa arm was 7.6 months vs. median PFS of 4.9 months in the control arm. The safety profile was generally consistent with the primary analysis. Discontinuations due to adverse events were infrequent in both arms of the trial, with 5.9% in the Tukysa arm and 4.1% in the control arm. Tukysa in combination with trastuzumab and capecitabine was approved by the FDA in April 2020 for adult patients with advanced unresectable or metastatic HER2-positive breast cancer, including patients with brain metastases, who have received one or more prior anti-HER2-based regimens in the metastatic setting.

ShowHide Related Items >><<
SGEN Seagen
$148.11 /

-5.87 (-3.81%)

SGEN Seagen
$148.11 /

-5.87 (-3.81%)

05/17/21 Evercore ISI
Seagen initiated with an In Line at Evercore ISI
04/30/21 Piper Sandler
Seagen price target lowered to $160 from $170 at Piper Sandler
04/12/21 B. Riley
B. Riley calls Agenus the next Seagen, reiterates $8 target
03/30/21 Credit Suisse
Seagen initiated with a Neutral at Credit Suisse
SGEN Seagen
$148.11 /

-5.87 (-3.81%)

SGEN Seagen
$148.11 /

-5.87 (-3.81%)

Conference/Events
American Association for Cancer Research to hold a virtual meeting » 04:55
05/21/21
05/21
04:55
05/21/21
04:55
WUXIF

WuXi AppTec

$19.88 /

+ (+0.00%)

, ABBV

AbbVie

$117.11 /

+1.21 (+1.04%)

, AMGN

Amgen

$251.82 /

+3.19 (+1.28%)

, ALPMY

Astellas Pharma

$15.48 /

+0.09 (+0.58%)

, AZN

AstraZeneca

$57.47 /

+1.13 (+2.01%)

, BGNE

BeiGene

$344.38 /

+11.75 (+3.53%)

, BMY

Bristol-Myers

$66.98 /

+1.42 (+2.17%)

, GILD

Gilead

$69.35 /

+0.85 (+1.24%)

, GSK

GlaxoSmithKline

$39.04 /

+0.327049 (+0.84%)

, INCY

Incyte

$83.48 /

+1.76 (+2.15%)

, JAZZ

Jazz Pharmaceuticals

$178.65 /

+3.605 (+2.06%)

, LLY

Eli Lilly

$199.53 /

+3.07 (+1.56%)

, MRK

Merck

$79.66 /

+0.29 (+0.37%)

, NVS

Novartis

$87.93 /

+0.28 (+0.32%)

, NVCR

Novocure

$182.30 /

+5.62 (+3.18%)

, PFE

Pfizer

$40.13 /

+0.285 (+0.72%)

, SNY

Sanofi

$54.07 /

+1.18 (+2.23%)

, SGEN

Seagen

$155.48 /

+6.705 (+4.51%)

, TAK

Takeda Pharmaceutical

$17.32 /

+0.17 (+0.99%)

AACR Virtual Annual…

AACR Virtual Annual Meeting 2021 will be held on May 17-21.Webcast Link

ShowHide Related Items >><<
TAK Takeda Pharmaceutical
$17.32 /

+0.17 (+0.99%)

SNY Sanofi
$54.07 /

+1.18 (+2.23%)

SGEN Seagen
$155.48 /

+6.705 (+4.51%)

PFE Pfizer
$40.13 /

+0.285 (+0.72%)

NVS Novartis
$87.93 /

+0.28 (+0.32%)

NVCR Novocure
$182.30 /

+5.62 (+3.18%)

MRK Merck
$79.66 /

+0.29 (+0.37%)

LLY Eli Lilly
$199.53 /

+3.07 (+1.56%)

JAZZ Jazz Pharmaceuticals
$178.65 /

+3.605 (+2.06%)

INCY Incyte
$83.48 /

+1.76 (+2.15%)

GSK GlaxoSmithKline
$39.04 /

+0.327049 (+0.84%)

GILD Gilead
$69.35 /

+0.85 (+1.24%)

BMY Bristol-Myers
$66.98 /

+1.42 (+2.17%)

BGNE BeiGene
$344.38 /

+11.75 (+3.53%)

AZN AstraZeneca
$57.47 /

+1.13 (+2.01%)

AMGN Amgen
$251.82 /

+3.19 (+1.28%)

ALPMY Astellas Pharma
$15.48 /

+0.09 (+0.58%)

ABBV AbbVie
$117.11 /

+1.21 (+1.04%)

WUXIF WuXi AppTec
$19.88 /

+ (+0.00%)

09/30/20 Goldman Sachs
WuXi AppTec reinstated with a Buy at Goldman Sachs
ABBV AbbVie
$117.11 /

+1.21 (+1.04%)

05/19/21 Piper Sandler
Piper 'incrementally bullish' on Biohaven, AbbVie migraine drugs
05/13/21 Cantor Fitzgerald
Soliton downgraded to Neutral from Overweight at Cantor Fitzgerald
05/11/21 Maxim
Soliton downgraded to Hold from Buy at Maxim
05/03/21 Mizuho
AbbVie price target raised to $128 from $126 at Mizuho
AMGN Amgen
$251.82 /

+3.19 (+1.28%)

05/03/21 Oppenheimer
Amgen price target lowered to $265 from $275 at Oppenheimer
04/28/21 Atlantic Equities
Amgen downgraded to Underweight from Neutral at Atlantic Equities
04/28/21 Credit Suisse
Amgen price target lowered to $259 from $265 at Credit Suisse
04/28/21 BMO Capital
Amgen price target lowered to $296 from $301 at BMO Capital
ALPMY Astellas Pharma
$15.48 /

+0.09 (+0.58%)

10/13/20 JMP Securities
Seagen price target raised to $216 from $200 at JMP Securities
05/26/20 Goldman Sachs
Astellas Pharma upgraded to Buy on raised PADCEV estimates at Goldman Sachs
05/26/20 Goldman Sachs
Astellas Pharma upgraded to Buy from Neutral at Goldman Sachs
AZN AstraZeneca
$57.47 /

+1.13 (+2.01%)

05/05/21 Oppenheimer
Alexion upgraded to Outperform from Perform at Oppenheimer
04/30/21 Wedbush
Alexion's Q1 report 'uneventful' after FTC grants deal clearance, says Wedbush
04/14/21 Guggenheim
Emergent BioSolutions price target lowered to $110 from $130 at Guggenheim
04/12/21
Fly Intel: Top five analyst downgrades
BGNE BeiGene
$344.38 /

+11.75 (+3.53%)

03/16/21 HSBC
BeiGene price target raised to $385 from $296 at HSBC
03/08/21 China Renaissance
BeiGene initiated with a Buy at China Renaissance
03/04/21 Goldman Sachs
Five Prime acquisition 'a strategic positive' for Amgen, says Goldman Sachs
03/01/21
Fly Intel: Top five analyst downgrades
BMY Bristol-Myers
$66.98 /

+1.42 (+2.17%)

05/05/21 Wells Fargo
Wells sees 'limited impact' on Iovance's lifileucel from Keytruda/Yervoy data
04/30/21
Fly Intel: Top five analyst downgrades
04/30/21 Morgan Stanley
Bristol-Myers downgraded to Equal Weight on pipeline questions at Morgan Stanley
04/30/21 Morgan Stanley
Bristol-Myers downgraded to Equal Weight from Overweight at Morgan Stanley
GILD Gilead
$69.35 /

+0.85 (+1.24%)

04/01/21
Fly Intel: Top five analyst upgrades
04/01/21 Bernstein
Gilead upgraded to Outperform from Market Perform at Bernstein
03/30/21 Redburn
Gilead upgraded to Buy from Neutral at Redburn
03/15/21 Mizuho
Merck's Gilead collaboration likely to broaden reach of islatravir, says Mizuho
GSK GlaxoSmithKline
$39.04 /

+0.327049 (+0.84%)

05/11/21 UBS
GlaxoSmithKline price target raised to 1,370 GBp from 1,360 GBp at UBS
04/30/21 Deutsche Bank
GlaxoSmithKline price target raised to 1,200 GBp at Deutsche Bank
04/20/21 Morgan Stanley
GlaxoSmithKline price target lowered to 1,550 GBp at Morgan Stanley
04/20/21 UBS
GlaxoSmithKline price target raised to 1,360 GBp from 1,320 GBp at UBS
INCY Incyte
$83.48 /

+1.76 (+2.15%)

02/10/21 SVB Leerink
Incyte downgraded to Market Perform from Outperform at SVB Leerink
01/07/21 Truist
Incyte initiated with a Buy at Truist
01/07/21 Truist
Incyte initiated with a Buy at Truist
01/04/21 Guggenheim
Incyte upgraded to Buy from Neutral at Guggenheim
JAZZ Jazz Pharmaceuticals
$178.65 /

+3.605 (+2.06%)

05/19/21
Fly Intel: Top five analyst initiations
05/19/21 JPMorgan
Jazz Pharmaceuticals resumed with an Overweight at JPMorgan
05/17/21 H.C. Wainwright
Jazz Pharmaceuticals price target raised to $212 from $207 at H.C. Wainwright
04/21/21 Cantor Fitzgerald
Jazz Pharmaceuticals price target raised to $198 from $185 at Cantor Fitzgerald
LLY Eli Lilly
$199.53 /

+3.07 (+1.56%)

04/28/21 Mizuho
Eli Lilly price target lowered to $216 from $228 at Mizuho
04/28/21 Barclays
Eli Lilly price target lowered to $227 from $232 at Barclays
04/12/21 Benchmark
Benchmark sees full FDA approval of Regeneron's REGEN-COV coming
04/06/21 JPMorgan
JPMorgan survey 'broadly positive' on Eli Lilly Alzheimer's drug
MRK Merck
$79.66 /

+0.29 (+0.37%)

05/20/21
Fly Intel: Top five analyst downgrades
05/20/21 Argus
Merck downgraded to Hold at Argus ahead of Organon spinoff
05/20/21 Argus
Merck downgraded to Hold from Buy at Argus
05/05/21 BTIG
Mereo BioPharma initiated with a Buy at BTIG
NVS Novartis
$87.93 /

+0.28 (+0.32%)

05/11/21 Morgan Stanley
Novartis price target lowered to CHF 99 from CHF 102 at Morgan Stanley
04/28/21 JPMorgan
Novartis price target lowered to CHF 80 from CHF 85 at JPMorgan
04/28/21 Oddo BHF
Novartis upgraded to Outperform from Neutral at Oddo BHF
04/19/21 UBS
Novartis price target raised to CHF 96 from CHF 95 at UBS
NVCR Novocure
$182.30 /

+5.62 (+3.18%)

04/19/21 Truist
Novocure price target raised to $142 from $132 at Truist
04/14/21
Fly Intel: Top five analyst downgrades
04/14/21 Northland
Novocure price target raised to $250 from $200 at Northland
04/14/21 Wedbush
Novocure downgraded to Underperform at Wedbush after LUNAR update
PFE Pfizer
$40.13 /

+0.285 (+0.72%)

05/18/21 William Blair
William Blair says continued lack of '9001 safety signals positive for Sarepta
05/12/21 Canaccord
BioNTech price target raised to $240 from $130 at Canaccord
05/11/21 SVB Leerink
BioNTech price target raised to $159 from $118 at SVB Leerink
05/10/21 Morgan Stanley
Pfizer price target raised to $42 from $38 at Morgan Stanley
SNY Sanofi
$54.07 /

+1.18 (+2.23%)

04/30/21 Deutsche Bank
Sanofi price target raised to EUR 75 from EUR 70 at Deutsche Bank
04/29/21 Barclays
Sanofi price target raised to EUR 90 from EUR 85 at Barclays
04/28/21 Stifel
Protalix, Sanofi updates may signal headwinds for Avrobio, Amicus, says Stifel
04/06/21 Barclays
Sanofi price target raised to EUR 85 from EUR 80 at Barclays
SGEN Seagen
$155.48 /

+6.705 (+4.51%)

05/17/21 Evercore ISI
Seagen initiated with an In Line at Evercore ISI
04/30/21 Piper Sandler
Seagen price target lowered to $160 from $170 at Piper Sandler
04/12/21 B. Riley
B. Riley calls Agenus the next Seagen, reiterates $8 target
03/30/21 Credit Suisse
Seagen initiated with a Neutral at Credit Suisse
TAK Takeda Pharmaceutical
$17.32 /

+0.17 (+0.99%)

04/27/21 Chardan
LogicBio collaborations may signal recognition of platforms, says Chardan
04/19/21 JPMorgan
Takeda Pharmaceutical downgraded to Neutral on R&D investments at JPMorgan
04/19/21 JPMorgan
Takeda Pharmaceutical downgraded to Neutral from Overweight at JPMorgan
04/15/21 Oppenheimer
Molecular Templates price target lowered to $13 from $18 at Oppenheimer
TAK Takeda Pharmaceutical
$17.32 /

+0.17 (+0.99%)

SNY Sanofi
$54.07 /

+1.18 (+2.23%)

SGEN Seagen
$155.48 /

+6.705 (+4.51%)

PFE Pfizer
$40.13 /

+0.285 (+0.72%)

NVS Novartis
$87.93 /

+0.28 (+0.32%)

NVCR Novocure
$182.30 /

+5.62 (+3.18%)

MRK Merck
$79.66 /

+0.29 (+0.37%)

LLY Eli Lilly
$199.53 /

+3.07 (+1.56%)

JAZZ Jazz Pharmaceuticals
$178.65 /

+3.605 (+2.06%)

INCY Incyte
$83.48 /

+1.76 (+2.15%)

GSK GlaxoSmithKline
$39.04 /

+0.327049 (+0.84%)

GILD Gilead
$69.35 /

+0.85 (+1.24%)

BMY Bristol-Myers
$66.98 /

+1.42 (+2.17%)

BGNE BeiGene
$344.38 /

+11.75 (+3.53%)

AZN AstraZeneca
$57.47 /

+1.13 (+2.01%)

AMGN Amgen
$251.82 /

+3.19 (+1.28%)

ABBV AbbVie
$117.11 /

+1.21 (+1.04%)

  • 02
    Dec
TAK Takeda Pharmaceutical
$17.32 /

+0.17 (+0.99%)

SNY Sanofi
$54.07 /

+1.18 (+2.23%)

PFE Pfizer
$40.13 /

+0.285 (+0.72%)

NVS Novartis
$87.93 /

+0.28 (+0.32%)

MRK Merck
$79.66 /

+0.29 (+0.37%)

LLY Eli Lilly
$199.53 /

+3.07 (+1.56%)

JAZZ Jazz Pharmaceuticals
$178.65 /

+3.605 (+2.06%)

INCY Incyte
$83.48 /

+1.76 (+2.15%)

GSK GlaxoSmithKline
$39.04 /

+0.327049 (+0.84%)

GILD Gilead
$69.35 /

+0.85 (+1.24%)

BMY Bristol-Myers
$66.98 /

+1.42 (+2.17%)

AZN AstraZeneca
$57.47 /

+1.13 (+2.01%)

AMGN Amgen
$251.82 /

+3.19 (+1.28%)

ABBV AbbVie
$117.11 /

+1.21 (+1.04%)

TAK Takeda Pharmaceutical
$17.32 /

+0.17 (+0.99%)

SNY Sanofi
$54.07 /

+1.18 (+2.23%)

SGEN Seagen
$155.48 /

+6.705 (+4.51%)

PFE Pfizer
$40.13 /

+0.285 (+0.72%)

NVS Novartis
$87.93 /

+0.28 (+0.32%)

NVCR Novocure
$182.30 /

+5.62 (+3.18%)

MRK Merck
$79.66 /

+0.29 (+0.37%)

LLY Eli Lilly
$199.53 /

+3.07 (+1.56%)

JAZZ Jazz Pharmaceuticals
$178.65 /

+3.605 (+2.06%)

INCY Incyte
$83.48 /

+1.76 (+2.15%)

GSK GlaxoSmithKline
$39.04 /

+0.327049 (+0.84%)

GILD Gilead
$69.35 /

+0.85 (+1.24%)

BMY Bristol-Myers
$66.98 /

+1.42 (+2.17%)

AZN AstraZeneca
$57.47 /

+1.13 (+2.01%)

AMGN Amgen
$251.82 /

+3.19 (+1.28%)

ABBV AbbVie
$117.11 /

+1.21 (+1.04%)

TAK Takeda Pharmaceutical
$17.32 /

+0.17 (+0.99%)

PFE Pfizer
$40.13 /

+0.285 (+0.72%)

MRK Merck
$79.66 /

+0.29 (+0.37%)

LLY Eli Lilly
$199.53 /

+3.07 (+1.56%)

INCY Incyte
$83.48 /

+1.76 (+2.15%)

GSK GlaxoSmithKline
$39.04 /

+0.327049 (+0.84%)

GILD Gilead
$69.35 /

+0.85 (+1.24%)

BMY Bristol-Myers
$66.98 /

+1.42 (+2.17%)

AZN AstraZeneca
$57.47 /

+1.13 (+2.01%)

AMGN Amgen
$251.82 /

+3.19 (+1.28%)

ABBV AbbVie
$117.11 /

+1.21 (+1.04%)

Conference/Events
American Association for Cancer Research to hold a virtual meeting » 04:55
05/20/21
05/20
04:55
05/20/21
04:55
WUXIF

WuXi AppTec

$19.88 /

+ (+0.00%)

, ABBV

AbbVie

$115.90 /

-1.32 (-1.13%)

, AMGN

Amgen

$248.70 /

-2.13 (-0.85%)

, ALPMY

Astellas Pharma

$15.39 /

+0.04 (+0.26%)

, AZN

AstraZeneca

$56.34 /

+0.34 (+0.61%)

, BGNE

BeiGene

$335.13 /

-3.1 (-0.92%)

, BMY

Bristol-Myers

$65.57 /

-0.03 (-0.05%)

, GILD

Gilead

$68.51 /

-0.33 (-0.48%)

, GSK

GlaxoSmithKline

$38.71 /

-0.320049 (-0.82%)

, INCY

Incyte

$81.73 /

-0.12 (-0.15%)

, JAZZ

Jazz Pharmaceuticals

$175.19 /

-0.04 (-0.02%)

, LLY

Eli Lilly

$196.56 /

+1.97 (+1.01%)

, MRK

Merck

$79.37 /

-0.01 (-0.01%)

, NVS

Novartis

$87.68 /

-1.08 (-1.22%)

, NVCR

Novocure

$176.74 /

-3.775 (-2.09%)

, PFE

Pfizer

$39.84 /

-0.2 (-0.50%)

, SNY

Sanofi

$52.89 /

-0.5599 (-1.05%)

, SGEN

Seagen

$148.78 /

+0.385 (+0.26%)

, TAK

Takeda Pharmaceutical

$17.15 /

-0.09 (-0.52%)

AACR Virtual Annual…

AACR Virtual Annual Meeting 2021 will be held on May 17-21.Webcast Link

ShowHide Related Items >><<
TAK Takeda Pharmaceutical
$17.15 /

-0.09 (-0.52%)

SNY Sanofi
$52.89 /

-0.5599 (-1.05%)

SGEN Seagen
$148.78 /

+0.385 (+0.26%)

PFE Pfizer
$39.84 /

-0.2 (-0.50%)

NVS Novartis
$87.68 /

-1.08 (-1.22%)

NVCR Novocure
$176.74 /

-3.775 (-2.09%)

MRK Merck
$79.37 /

-0.01 (-0.01%)

LLY Eli Lilly
$196.56 /

+1.97 (+1.01%)

JAZZ Jazz Pharmaceuticals
$175.19 /

-0.04 (-0.02%)

INCY Incyte
$81.73 /

-0.12 (-0.15%)

GSK GlaxoSmithKline
$38.71 /

-0.320049 (-0.82%)

GILD Gilead
$68.51 /

-0.33 (-0.48%)

BMY Bristol-Myers
$65.57 /

-0.03 (-0.05%)

BGNE BeiGene
$335.13 /

-3.1 (-0.92%)

AZN AstraZeneca
$56.34 /

+0.34 (+0.61%)

AMGN Amgen
$248.70 /

-2.13 (-0.85%)

ALPMY Astellas Pharma
$15.39 /

+0.04 (+0.26%)

ABBV AbbVie
$115.90 /

-1.32 (-1.13%)

WUXIF WuXi AppTec
$19.88 /

+ (+0.00%)

09/30/20 Goldman Sachs
WuXi AppTec reinstated with a Buy at Goldman Sachs
ABBV AbbVie
$115.90 /

-1.32 (-1.13%)

05/19/21 Piper Sandler
Piper 'incrementally bullish' on Biohaven, AbbVie migraine drugs
05/13/21 Cantor Fitzgerald
Soliton downgraded to Neutral from Overweight at Cantor Fitzgerald
05/11/21 Maxim
Soliton downgraded to Hold from Buy at Maxim
05/03/21 Mizuho
AbbVie price target raised to $128 from $126 at Mizuho
AMGN Amgen
$248.70 /

-2.13 (-0.85%)

05/03/21 Oppenheimer
Amgen price target lowered to $265 from $275 at Oppenheimer
04/28/21 Atlantic Equities
Amgen downgraded to Underweight from Neutral at Atlantic Equities
04/28/21 Credit Suisse
Amgen price target lowered to $259 from $265 at Credit Suisse
04/28/21 BMO Capital
Amgen price target lowered to $296 from $301 at BMO Capital
ALPMY Astellas Pharma
$15.39 /

+0.04 (+0.26%)

10/13/20 JMP Securities
Seagen price target raised to $216 from $200 at JMP Securities
05/26/20 Goldman Sachs
Astellas Pharma upgraded to Buy on raised PADCEV estimates at Goldman Sachs
05/26/20 Goldman Sachs
Astellas Pharma upgraded to Buy from Neutral at Goldman Sachs
AZN AstraZeneca
$56.34 /

+0.34 (+0.61%)

05/05/21 Oppenheimer
Alexion upgraded to Outperform from Perform at Oppenheimer
04/30/21 Wedbush
Alexion's Q1 report 'uneventful' after FTC grants deal clearance, says Wedbush
04/14/21 Guggenheim
Emergent BioSolutions price target lowered to $110 from $130 at Guggenheim
04/12/21
Fly Intel: Top five analyst downgrades
BGNE BeiGene
$335.13 /

-3.1 (-0.92%)

03/16/21 HSBC
BeiGene price target raised to $385 from $296 at HSBC
03/08/21 China Renaissance
BeiGene initiated with a Buy at China Renaissance
03/04/21 Goldman Sachs
Five Prime acquisition 'a strategic positive' for Amgen, says Goldman Sachs
03/01/21
Fly Intel: Top five analyst downgrades
BMY Bristol-Myers
$65.57 /

-0.03 (-0.05%)

05/05/21 Wells Fargo
Wells sees 'limited impact' on Iovance's lifileucel from Keytruda/Yervoy data
04/30/21
Fly Intel: Top five analyst downgrades
04/30/21 Morgan Stanley
Bristol-Myers downgraded to Equal Weight on pipeline questions at Morgan Stanley
04/30/21 Morgan Stanley
Bristol-Myers downgraded to Equal Weight from Overweight at Morgan Stanley
GILD Gilead
$68.51 /

-0.33 (-0.48%)

04/01/21
Fly Intel: Top five analyst upgrades
04/01/21 Bernstein
Gilead upgraded to Outperform from Market Perform at Bernstein
03/30/21 Redburn
Gilead upgraded to Buy from Neutral at Redburn
03/15/21 Mizuho
Merck's Gilead collaboration likely to broaden reach of islatravir, says Mizuho
GSK GlaxoSmithKline
$38.71 /

-0.320049 (-0.82%)

05/11/21 UBS
GlaxoSmithKline price target raised to 1,370 GBp from 1,360 GBp at UBS
04/30/21 Deutsche Bank
GlaxoSmithKline price target raised to 1,200 GBp at Deutsche Bank
04/20/21 Morgan Stanley
GlaxoSmithKline price target lowered to 1,550 GBp at Morgan Stanley
04/20/21 UBS
GlaxoSmithKline price target raised to 1,360 GBp from 1,320 GBp at UBS
INCY Incyte
$81.73 /

-0.12 (-0.15%)

02/10/21 SVB Leerink
Incyte downgraded to Market Perform from Outperform at SVB Leerink
01/07/21 Truist
Incyte initiated with a Buy at Truist
01/07/21 Truist
Incyte initiated with a Buy at Truist
01/04/21 Guggenheim
Incyte upgraded to Buy from Neutral at Guggenheim
JAZZ Jazz Pharmaceuticals
$175.19 /

-0.04 (-0.02%)

05/19/21
Fly Intel: Top five analyst initiations
05/19/21 JPMorgan
Jazz Pharmaceuticals resumed with an Overweight at JPMorgan
05/17/21 H.C. Wainwright
Jazz Pharmaceuticals price target raised to $212 from $207 at H.C. Wainwright
04/21/21 Cantor Fitzgerald
Jazz Pharmaceuticals price target raised to $198 from $185 at Cantor Fitzgerald
LLY Eli Lilly
$196.56 /

+1.97 (+1.01%)

04/28/21 Mizuho
Eli Lilly price target lowered to $216 from $228 at Mizuho
04/28/21 Barclays
Eli Lilly price target lowered to $227 from $232 at Barclays
04/12/21 Benchmark
Benchmark sees full FDA approval of Regeneron's REGEN-COV coming
04/06/21 JPMorgan
JPMorgan survey 'broadly positive' on Eli Lilly Alzheimer's drug
MRK Merck
$79.37 /

-0.01 (-0.01%)

05/05/21 BTIG
Mereo BioPharma initiated with a Buy at BTIG
04/20/21 Citi
GlaxoSmithKline collaboration with Merck would be 'win-win,' says Citi
04/16/21 William Blair
Atea selloff on Merck update unwarranted, says William Blair
04/12/21 B. Riley
B. Riley calls Agenus the next Seagen, reiterates $8 target
NVS Novartis
$87.68 /

-1.08 (-1.22%)

05/11/21 Morgan Stanley
Novartis price target lowered to CHF 99 from CHF 102 at Morgan Stanley
04/28/21 JPMorgan
Novartis price target lowered to CHF 80 from CHF 85 at JPMorgan
04/28/21 Oddo BHF
Novartis upgraded to Outperform from Neutral at Oddo BHF
04/19/21 UBS
Novartis price target raised to CHF 96 from CHF 95 at UBS
NVCR Novocure
$176.74 /

-3.775 (-2.09%)

04/19/21 Truist
Novocure price target raised to $142 from $132 at Truist
04/14/21
Fly Intel: Top five analyst downgrades
04/14/21 Northland
Novocure price target raised to $250 from $200 at Northland
04/14/21 Wedbush
Novocure downgraded to Underperform at Wedbush after LUNAR update
PFE Pfizer
$39.84 /

-0.2 (-0.50%)

05/18/21 William Blair
William Blair says continued lack of '9001 safety signals positive for Sarepta
05/12/21 Canaccord
BioNTech price target raised to $240 from $130 at Canaccord
05/11/21 SVB Leerink
BioNTech price target raised to $159 from $118 at SVB Leerink
05/10/21 Morgan Stanley
Pfizer price target raised to $42 from $38 at Morgan Stanley
SNY Sanofi
$52.89 /

-0.5599 (-1.05%)

04/30/21 Deutsche Bank
Sanofi price target raised to EUR 75 from EUR 70 at Deutsche Bank
04/29/21 Barclays
Sanofi price target raised to EUR 90 from EUR 85 at Barclays
04/28/21 Stifel
Protalix, Sanofi updates may signal headwinds for Avrobio, Amicus, says Stifel
04/06/21 Barclays
Sanofi price target raised to EUR 85 from EUR 80 at Barclays
SGEN Seagen
$148.78 /

+0.385 (+0.26%)

05/17/21 Evercore ISI
Seagen initiated with an In Line at Evercore ISI
04/30/21 Piper Sandler
Seagen price target lowered to $160 from $170 at Piper Sandler
03/30/21 Credit Suisse
Seagen initiated with a Neutral at Credit Suisse
TAK Takeda Pharmaceutical
$17.15 /

-0.09 (-0.52%)

04/27/21 Chardan
LogicBio collaborations may signal recognition of platforms, says Chardan
04/19/21 JPMorgan
Takeda Pharmaceutical downgraded to Neutral on R&D investments at JPMorgan
04/19/21 JPMorgan
Takeda Pharmaceutical downgraded to Neutral from Overweight at JPMorgan
04/15/21 Oppenheimer
Molecular Templates price target lowered to $13 from $18 at Oppenheimer
TAK Takeda Pharmaceutical
$17.15 /

-0.09 (-0.52%)

SNY Sanofi
$52.89 /

-0.5599 (-1.05%)

SGEN Seagen
$148.78 /

+0.385 (+0.26%)

PFE Pfizer
$39.84 /

-0.2 (-0.50%)

NVS Novartis
$87.68 /

-1.08 (-1.22%)

NVCR Novocure
$176.74 /

-3.775 (-2.09%)

MRK Merck
$79.37 /

-0.01 (-0.01%)

LLY Eli Lilly
$196.56 /

+1.97 (+1.01%)

JAZZ Jazz Pharmaceuticals
$175.19 /

-0.04 (-0.02%)

INCY Incyte
$81.73 /

-0.12 (-0.15%)

GSK GlaxoSmithKline
$38.71 /

-0.320049 (-0.82%)

GILD Gilead
$68.51 /

-0.33 (-0.48%)

BMY Bristol-Myers
$65.57 /

-0.03 (-0.05%)

BGNE BeiGene
$335.13 /

-3.1 (-0.92%)

AZN AstraZeneca
$56.34 /

+0.34 (+0.61%)

AMGN Amgen
$248.70 /

-2.13 (-0.85%)

ABBV AbbVie
$115.90 /

-1.32 (-1.13%)

  • 02
    Dec
TAK Takeda Pharmaceutical
$17.15 /

-0.09 (-0.52%)

SNY Sanofi
$52.89 /

-0.5599 (-1.05%)

PFE Pfizer
$39.84 /

-0.2 (-0.50%)

NVS Novartis
$87.68 /

-1.08 (-1.22%)

MRK Merck
$79.37 /

-0.01 (-0.01%)

LLY Eli Lilly
$196.56 /

+1.97 (+1.01%)

JAZZ Jazz Pharmaceuticals
$175.19 /

-0.04 (-0.02%)

INCY Incyte
$81.73 /

-0.12 (-0.15%)

GSK GlaxoSmithKline
$38.71 /

-0.320049 (-0.82%)

GILD Gilead
$68.51 /

-0.33 (-0.48%)

BMY Bristol-Myers
$65.57 /

-0.03 (-0.05%)

AZN AstraZeneca
$56.34 /

+0.34 (+0.61%)

AMGN Amgen
$248.70 /

-2.13 (-0.85%)

ABBV AbbVie
$115.90 /

-1.32 (-1.13%)

TAK Takeda Pharmaceutical
$17.15 /

-0.09 (-0.52%)

SNY Sanofi
$52.89 /

-0.5599 (-1.05%)

SGEN Seagen
$148.78 /

+0.385 (+0.26%)

PFE Pfizer
$39.84 /

-0.2 (-0.50%)

NVS Novartis
$87.68 /

-1.08 (-1.22%)

NVCR Novocure
$176.74 /

-3.775 (-2.09%)

MRK Merck
$79.37 /

-0.01 (-0.01%)

LLY Eli Lilly
$196.56 /

+1.97 (+1.01%)

JAZZ Jazz Pharmaceuticals
$175.19 /

-0.04 (-0.02%)

INCY Incyte
$81.73 /

-0.12 (-0.15%)

GSK GlaxoSmithKline
$38.71 /

-0.320049 (-0.82%)

GILD Gilead
$68.51 /

-0.33 (-0.48%)

BMY Bristol-Myers
$65.57 /

-0.03 (-0.05%)

AZN AstraZeneca
$56.34 /

+0.34 (+0.61%)

AMGN Amgen
$248.70 /

-2.13 (-0.85%)

ABBV AbbVie
$115.90 /

-1.32 (-1.13%)

TAK Takeda Pharmaceutical
$17.15 /

-0.09 (-0.52%)

PFE Pfizer
$39.84 /

-0.2 (-0.50%)

MRK Merck
$79.37 /

-0.01 (-0.01%)

LLY Eli Lilly
$196.56 /

+1.97 (+1.01%)

INCY Incyte
$81.73 /

-0.12 (-0.15%)

GSK GlaxoSmithKline
$38.71 /

-0.320049 (-0.82%)

GILD Gilead
$68.51 /

-0.33 (-0.48%)

BMY Bristol-Myers
$65.57 /

-0.03 (-0.05%)

AZN AstraZeneca
$56.34 /

+0.34 (+0.61%)

AMGN Amgen
$248.70 /

-2.13 (-0.85%)

ABBV AbbVie
$115.90 /

-1.32 (-1.13%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.